0001564590-20-052589 | 10-Q | XBRL Viewer

ABG Profit Participation Arrangement

3.	ABG Profit Participation Arrangement

The Company entered into a Profit Participation Arrangement (“ABG Arrangement”) with ABG Intermediate Holdings 2, LLC (“ABG”) on January 14, 2019 as described in the Annual Financial Statements.

On January 24, 2020, the Company entered into (i) an Amended and Restated Profit Participation Agreement (the “A&R Profit Participation Agreement”) with ABG, which amended and restated in its entirety the Profit Participation Agreement, dated January 14, 2019, and (ii) the First Amendment to Payment Agreement with ABG (the “Payment Agreement Amendment”), which amends the Payment Agreement, dated January 14, 2019. The Company and ABG agreed that Tilray no longer has any obligation to pay the additional consideration with an aggregate value of $83,333 in cash or in shares of Class 2 common stock. In addition, the Company is not entitled to any guaranteed minimum participation rights and beginning January 1, 2020 through December 31, 2028, the Company agreed that it is not entitled to any participation rights until such participation rights with respect to each contract year exceeds $10,000, and in the event the participation rights thresholds are achieved, the Company is entitled to the full 49% participation rights.

As a result of entering into the A&R Profit Participation Agreement and the Payment Agreement Amendment, the Company derecognized the ABG finance receivable, $7,011 of which was recorded to impairment of assets through the statements of net loss and comprehensive loss and $28,900 of which was recorded through accumulated deficit in January 2020.

The Company entered into a Trademark License Agreement with ABG on April 1, 2019 for the use of the Prince trademark (“ABG Prince Agreement”). Under the ABG Prince Agreement, the Company pays a royalty on actual product sales in addition to a guaranteed minimum royalty payment (“GMR”) of $500 on April 1, 2019, October 1, 2019, January 1, 2020 and July 1, 2020, with subsequent quarterly payments of $375 commencing January 1, 2021 until the maturity date of December 31, 2025.

Inventory

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventory

Inventory is comprised of the following items:

	September 30, 2020		December 31, 2019
Raw materials	$	15,338	$	15,926
Work-in-process		59,863		53,973
Finished goods		14,716		17,962
Total	$	89,917	$	87,861

Inventory is written down for any obsolescence, spoilage and excess inventory or when the net realizable value of inventory is less than the carrying value. Inventory valuation adjustments included in cost of sales on the statements of net loss and comprehensive loss is comprised of the following:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Raw materials	$	173	$	—	$	384	$	—
Work-in-process		11,164		201		30,656		726
Finished goods		2,106		—		5,076		—
Total	$	13,443	$	201	$	36,116	$	726

For the three and nine months ended September 30, 2020, cannabis products were written down by $13,318 and $31,626 (2019 – $124 and $610) and hemp products were written down by $125 and $4,490 (2019 – $77 and $116). In the three and nine months ended September 30, 2020, included in inventory valuation adjustments in cost of sales, $5,157 and $10,090 related to termination of a supply agreement; $4,934 relating to a loss on deposit payments for future purchases of inventory to secure supply (refer to Note 5) and $5,157 of additional termination penalties due to the same supplier. Also included in inventory valuation adjustments in cost of sales for the nine months ended September 30, 2020 is $1,800, relating to the destruction of unharvested flower as a result of the closure of the High Park Gardens facility (refer to Note 2).

Prepayments and Other Current Assets

9 Months Ended

Sep. 30, 2020

Prepaid Expense And Other Assets Current [Abstract]

Prepayments and Other Current Assets

5.	Prepayments and Other Current Assets

Prepayments and other current assets are comprised of the following items:

	September 30, 2020		December 31, 2019
Deposits	$	15,325	$	25,490
Prepayments		6,854		5,847
Taxes receivable		5,975		6,165
ABG finance receivable - current		—		671
Total	$	28,154	$	38,173

Deposits include advance payments on future purchases of inventory to secure supply. During the nine months ended September 30, 2020, the Company reached agreement with certain suppliers to terminate supply agreements. As a result, deposits have been written down by $4,934 in the Cannabis segment and were recorded in inventory valuation adjustments in the statements of net loss and comprehensive loss (refer to Note 4).

Investments

9 Months Ended

Sep. 30, 2020

Investments Debt And Equity Securities [Abstract]

Investments

6.	Investments

Other investments

Long-term investments are comprised of the following items:

	September 30, 2020		December 31, 2019
Equity investments at fair value	$	2,207	$	4,183
Equity investments under measurement alternative		14,738		14,954
Debt securities classified under available-for-sale method		5,765		5,047
Total other investments	$	22,710	$	24,184

Unrealized gains and losses recognized in other expense (income) during the three and nine months ended September 30, 2020 on equity investments still held at September 30, 2020 are losses of $506 and $1,272 (2019 – loss of $274 and gain of $264). There were no impairments or adjustments to equity investments under the measurement alternative for the three and nine months ended September 30, 2020 and September 30, 2019.

The Company’s debt securities accounted for under the available-for-sale method consist of convertible debt instruments with contractual maturities in 2022. Total unrealized loss of $148 in accumulated other comprehensive income at September 30, 2020 (December 31, 2019 - $302) relates to the long-term available-for-sale debt securities. The Company’s allowance for credit losses on debt securities classified as available-for-sale is $0 at September 30, 2020 (December 31, 2019 – $0) and no related credit loss expenses were recorded during the three and nine months ended September 30, 2020 (2019 – $0 and $0).

Equity method investments

Equity method investments are comprised of the Company’s joint venture with Anheuser-Busch InBev (“AB InBev”) in Plain Vanilla Research Limited Partnership (“Fluent”) and the Company’s joint venture with Cannfections Group Inc. (“Cannfections”). As of September 30, 2020, there are no changes to the status of the Company’s assessment of its joint ventures.

During the nine months ended September 30, 2020, the Company contributed $2,323 to Fluent (2019 - $10,090). The Company provides production support services to Fluent on a cost recovery basis. For the nine months ended September 30, 2020, total fees charged were $3,109 (2019 - $0). Total amounts included in accounts payable is $441 at September 30, 2020 (December 31, 2019 – accounts receivable of $388). At September 30, 2020, the maximum exposure to loss is limited to the Company’s equity investment in Fluent.

During the nine months ended September 30, 2020, the Company made no capital contributions to Cannfections (2019 - $3,600). At September 30, 2020, the maximum exposure to loss is limited to the Company’s equity investment in Cannfections.

The Company’s ownership interests in its equity method investments as of September 30, 2020 and December 31, 2019 and (loss) gain from equity method investments for the nine months ended September 30, 2020 were as follows:

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	September 30, 2020		September 30, 2020
Investment in Fluent	50%	$	5,147	$	(4,725	)
Investment in Cannfections	50%		3,764		230
Total equity method investments		$	8,911	$	(4,495	)

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	December 31, 2019		September 30, 2019
Investment in Fluent	50%	$	7,836	$	(1,837	)
Investment in Cannfections	50%		3,612		—
Total equity method investments		$	11,448	$	(1,837	)

Summary financial information for the Company’s equity method investments on an aggregate basis is as follows:

	September 30, 2020		December 31, 2019
Current assets	$	12,346	$	13,942
Noncurrent assets	$	5,205	$	4,987
Current liabilities	$	4,965	$	1,561
Noncurrent liabilities	$	—	$	—

	Nine months ended September 30,
	2020			2019
Revenue	$	4,854		$	—
Gross profit	$	2,032		$	—
Net loss	$	(8,991	)	$	(3,160	)

Allowance for Credit Losses

9 Months Ended

Sep. 30, 2020

Allowance For Credit Loss [Abstract]

Allowance for Credit Losses

7.	Allowance for Credit Losses

Accounts receivable

The Company maintains an allowance for credit losses at an amount sufficient to absorb losses inherent in the existing accounts receivable portfolio as of the reporting dates based on the estimate of expected net credit losses. The following table provides activity in the allowance for credit losses for the nine months ended September 30, 2020:


Allowance for credit losses, January 1, 2020	$	615
Provision for expected credit losses ⁽¹⁾		288
Write-offs charged against allowance		(74	)
Recoveries of amounts previously written off		—
Foreign currency translation adjustment		(3	)
Allowance for credit losses, September 30, 2020	$	826
Accounts receivable balance before allowance for credit losses and provision for sales returns, September 30, 2020	$	26,843

(1)	The provision for expected credit losses is recorded in general and administrative expenses.

Available-for-sale debt securities

The Company holds investments in two available-for-sale debt securities, one of which is in an unrealized loss position. The unrealized loss relates to an investment in the convertible debentures of a recreational cannabis company. This investment is deemed not to have a credit loss. The unrealized loss primarily reflects an extended period of general volatility in the cannabis industry, as well

as the more recent volatility in the overall economy due to COVID-19. The Company expects to recover the entire amortized cost basis of the security. The Company does not intend to sell the investment and it is not more likely than not that the Company will be required to sell the investment before recovery of its amortized cost basis. The following table provides the fair value and unrealized loss of the investment at September 30, 2020 and December 31, 2019:

	September 30, 2020		December 31, 2019
Fair value	$	1,124	$	945
Unrealized loss	$	148	$	302

Property and Equipment, Net

9 Months Ended

Sep. 30, 2020

Property Plant And Equipment [Abstract]

Property and Equipment, Net

8.	Property and Equipment, Net

Property and equipment, net consists of the following:

	September 30, 2020			December 31, 2019
Land	$	6,488		$	6,417
Buildings and leasehold improvements		108,021			109,172
Laboratory and manufacturing equipment		34,500			31,173
Office and computer equipment		1,779			2,659
Right-of-use assets under finance lease		14,415			14,753
Construction-in-process, not yet available for use		46,551			37,160
		211,754			201,334
Less: accumulated depreciation		(24,124	)		(17,117	)
Total	$	187,630		$	184,217

In connection with the Company’s closure of its High Park Gardens facility, the Company determined that the fair value of the land and buildings at the High Park Gardens facility (Level 2) was below its carrying value. The decline in fair value of the land and buildings at the High Park Gardens facility is primarily due to recent sales of similar properties resulting in a lower implied sale price per acre of land and greenhouse space. As a result, the Company incurred non-cash impairment charges of $13,616 presented in impairment of assets in the statements of net loss and comprehensive loss (refer to Note 2).

Refer to Note 18 for contractual commitments related to construction-in-process.

Goodwill

9 Months Ended

Sep. 30, 2020

Goodwill Disclosure [Abstract]

Goodwill

The following table shows the change in carrying amount of goodwill:

	Hemp			Cannabis			Total
Balance as of December 31, 2019	$	133,314		$	29,937		$	163,251
Foreign currency translation adjustment		(2,971	)		(685	)		(3,656	)
Balance as of September 30, 2020	$	130,343		$	29,252		$	159,595

Goodwill is tested for impairment annually, or more frequently when events or circumstances indicate that impairment may have occurred. At the end of the first quarter of 2020, the Company determined the hemp reporting unit, representing $130,343 of the $159,595 total goodwill, was at risk of having a carrying value exceeding the fair value. As a result, a quantitative test was performed to determine if impairment exists. In performing the Company’s impairment analysis, the fair value of the hemp reporting unit was determined primarily by discounting estimated future cash flows, which were determined based on revenue and expense growth assumptions ranging from 9% to 38%, at a weighted average cost of capital (discount rate) ranging from 10% to 12%. The discounted future cash flow model also made the key assumption that Cannabidiol (“CBD”) revenue will commence to build in the third quarter of 2021. The fair value of the hemp reporting unit was determined to exceed the carrying value by $76,998, or 26%, and no impairment was recorded. No triggers have been identified in subsequent quarters to perform additional quantitative tests.

A relatively small change in the underlying assumptions, including a 1% change in the weighted average cost of capital, continued lack of clarity from the Food and Drug Administration regarding approval of CBD, or the financial performance of the reporting unit in future years, may cause a change in the results of the impairment assessment in future periods and, as such, could result in an impairment of goodwill.

Intangible Assets

9 Months Ended

Sep. 30, 2020

Intangible Assets Net Excluding Goodwill [Abstract]

Intangible Assets

10.	Intangible Assets

Intangible assets are comprised of the following items:

	September 30,								December 31,
	2020								2019
	Cost		Accumulated Amortization		Impairment		Net		Cost		Accumulated Amortization		Impairment		Net
Definite-lived intangible assets:
Patent	$	669	$	131	$	538	$	—	$	716	$	99	$	—	$	617
Customer relationships		132,837		13,241		—		119,596		135,953		7,132		—		128,821
Developed technology		6,912		1,094		—		5,818		7,074		590		—		6,484
Websites		5,126		3,921		—		1,205		5,157		3,331		—		1,826
Trademarks and licenses		9,052		1,293		7,650		109		9,135		925		—		8,210
Total		154,596		19,680		8,188		126,728		158,035		12,077		—		145,958
Indefinite-lived intangible assets:
Cultivation license		10,239		—		10,239		—		10,689		—		—		10,689
Alef license		—		—		—		—		4,086		—		4,086		—
Trademarks		54,125		—		—		54,125		55,416		—		—		55,416
Rights under ABG Profit Participation Arrangement		16,765		—		16,765		—		119,366		—		102,601		16,765
Total		81,129		—		27,004		54,125		189,557		—		106,687		82,870
Total intangible assets		235,725		19,680		35,192		180,853	$	347,592	$	12,077	$	106,687	$	228,828

In connection with the Company’s closure of its High Park Gardens facility, the Company determined that the fair value of the indefinite-lived cultivation license was below carrying value. As a result, the Company incurred non-cash impairment charges of $10,239, representing the full net book value of the cultivation license, presented in impairment of assets in the statements of net loss and comprehensive loss (refer to Note 2).

In connection with the decreased demand projections of CBD products in the United States resulting in a reduced estimate of future cash flows, during the first quarter of 2020 the Company determined that the fair value of indefinite-lived rights under the ABG Profit Participation Arrangement and definite-lived trademarks under the Trademark and License Agreement with ABG for the use of the Prince trademark (“ABG Prince Agreement”) were below the carrying value. As a result, the Company incurred non-cash impairment charges of $16,765 and $6,063 representing the full net book values of the intangible assets relating to the ABG Profit Participation Agreement and ABG Prince Agreement respectively, presented in impairment of assets in the statements of net loss and comprehensive loss (refer to Note 3). In June 2020, the Company completed the separation from Smith & Sinclair and recognized additional non-cash impairment charges of $3,320 presented in impairment of assets in the statement of net loss and comprehensive loss, of which $2,126 related to other CBD trademarks and patents.

Amortization expenses for intangibles was $2,765 and $7,603 for the three and nine months ended September 30, 2020 (2019 – $2,529 and $6,131). Expected future amortization expenses for intangible assets as at September 30, 2020 are as follows:

Year ending December 31,	Amortization
2020 (remaining three months)	$	2,522
2021		9,801
2022		9,306
2023		9,078
2024		9,078
Thereafter		86,943
Total	$	126,728

Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2020

Payables And Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

11.	Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following items:

	September 30, 2020		December 31, 2019
Accrued interest on convertible notes	$	11,875	$	5,938
Accrued payroll and employment related withholding taxes		10,709		24,765
Other accrued expenses and current liabilities		8,031		17,032
ABG finance liability - current		1,125		1,500
Accrued interest on Senior Facility		422		—
Accrued legal and professional fees		364		1,174
Contingent consideration for acquisitions		—		420
Total accrued expenses and other current liabilities	$	32,526	$	50,829

During the nine months ended September 30, 2020, the Company reduced its employee headcount in portions of its global organization to meet the needs of the current industry environment. During the three and nine months ended September 30, 2020, the Company incurred $239 and $3,576, respectively (2019 – $0 and $0), in severance costs, of which $133 and $3,128 is included in salaries within general and administrative expenses and $106 and $448 is included in cost of sales. During the three and nine months ended September 30, 2020, severance costs of $239 and $2,432 are allocated to the cannabis reportable segment and $0 and $1,144 are allocated to the hemp reportable segment. Management continues to evaluate its cost structure and may take further actions in the future and incur additional related costs. The following table shows the reconciliation of the severance costs included within the accrued payroll and employment related withholding taxes balance above, relating to scheduled benefit payments which were communicated to employees prior to September 30, 2020:


Opening Balance as of January 1, 2020	$	—
Additional charges		3,575
Less payments made to employees		(3,393	)
Closing Balance as of September 30, 2020	$	182

Convertible Notes

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Convertible Notes

12.	Convertible Notes

The Company has convertible senior notes with a face value of $475,000. As of September 30, 2020, the convertible notes are not yet convertible and the Company is in compliance with all covenants.

The following table sets forth the net carrying amount of the convertible notes:

	September 30, 2020			December 31, 2019
5.00% Convertible Notes	$	475,000		$	475,000
Unamortized discount		(28,133	)		(34,219	)
Unamortized transaction costs		(8,713	)		(10,571	)
Net carrying amount	$	438,154		$	430,210

The following table sets forth total interest expense recognized related to the convertible notes:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Contractual coupon interest	$	5,938	$	5,938	$	17,813	$	17,813
Amortization of discount		2,059		1,969		6,087		5,790
Amortization of transaction costs		641		614		1,857		1,826
Total	$	8,638	$	8,521	$	25,757	$	25,429

Senior Facility

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Senior Facility

13.	Senior Facility

On February 28, 2020, High Park Holdings Ltd., a wholly owned subsidiary of the Company (the “Borrower”) entered into a credit agreement, denominated in Canadian dollars (“C$”), for a senior secured credit facility in a maximum aggregate principal amount of $59,600 (C$79,800) (the “Senior Facility”). An aggregate principal amount equal to $49,700 (C$66,500) was drawn on February 28, 2020 (the “Closing Date Draw”) and the Company submitted an irrevocable 30 day notice on May 4, 2020 to draw an additional $9,900 (C$13,300) (the “Additional Draw”).

On June 5, 2020, as a result of COVID-19 related financial markets conditions that affected the lender of the Senior Facility, and not because of any material changes to the business of Tilray or its subsidiaries, the lender requested that Tilray withdraw its outstanding request for the Additional Draw of $9,900 (C$13,300) under the Senior Facility. In exchange for the Company’s accommodation of the lender’s request to withdraw its funding request, the lender agreed to enter into the First Amendment of the Senior Facility (the “Amendment”). The Amendment provides for interest-only payments for the remainder of its term with all outstanding principal payments due at February 28, 2022. This will result in an aggregate balance of $47,355 (C$64,283) due at February 28, 2022. Additionally, and at such time as the lender’s business may allow, the lender may make the additional proceeds of $9,900 (C$13,300) available, at its sole discretion.

Concurrently, with the Amendment, the lender also approved the Company’s ability to sell the High Park Gardens facility, which is classified as assets held for sale (refer to Note 2), if and when Tilray so desires. As part of any sale of the High Park Gardens facility, the lender has agreed that the Company may retain 60% of any sales proceeds (net of all expenses, fees and taxes), and that the lender will receive 40% of all sales proceeds (net of all expenses, fees and taxes). All sales proceeds to the lender will be applied as a repayment of principal on the Senior Facility without any prepayment penalties or fees. The sale of the High Park Gardens facility is expected to be completed within the next twelve months. The Amendment did not meet the accounting criteria for debt extinguishment.

The Senior Facility bears interest on the outstanding principal balance at an annual rate equal to the Canadian prime rate plus 8.05%, calculated based on the daily outstanding balance of the Senior Facility calculated and compounded monthly in arrears and with no deemed reinvestment of monthly payments. Interest is due monthly throughout the term. The Company has the option to voluntarily prepay, without penalty, the outstanding amounts, in full or in part, at any time starting 6 months from the closing date subsequent to providing 75 days’ notice.

Transaction costs incurred on the Closing Date Draw were $3,306 (C$4,425). There were no fees incurred associated with the Amendment. Transaction costs are deferred and amortized as a component of interest expense over the estimated term using the effective interest rate method. On June 29, 2020, the lender notified the Company that it had exercised its unilateral right to syndicate $19,153 (C$26,000) of the Company’s Senior Facility in the aggregate principal amount of $59,600 (C$79,800). The Senior Facility’s terms otherwise remain unchanged.

The Senior Facility has first priority claims on all North American assets of the Company and contains certain affirmative and negative covenants. The operational covenant includes a minimum unrestricted cash threshold of $29,466 (C$40,000) in order for the Company to make additional capital expenditures and investments. The Senior Facility is collateralized against all real and personal property owned, leased and operated by the Company in North America, and any and all other property of the Company now existing and acquired in North America after the closing date. As of September 30, 2020, the Company was in compliance with all covenants set forth under the Senior Facility.

The following table sets forth the net carrying amount of the Senior Facility:

	September 30, 2020
Senior Facility	$	48,299
Unamortized transaction costs		(2,355	)
Net carrying amount	$	45,944
Less: current portion of Senior Facility		—
Total noncurrent portion of Senior Facility	$	45,944

The following table sets forth total interest expense recognized related to the Senior Facility:

	Three months ended September 30, 2020		Nine months ended September 30, 2020
Contractual interest at Canadian prime plus 8.05%	$	1,260	$	2,970
Amortization of transaction costs		407		943
Total	$	1,667	$	3,913

Registered Offering and Warrants

9 Months Ended

Sep. 30, 2020

Registered Offering and Warrants

14.	Registered Offering and Warrants

On March 17, 2020, the Company closed a registered offering of 7,250,000 shares of the Company’s Class 2 common stock for $4.76 per share with an equal number of accompanying warrants and 11,750,000 pre-funded warrants for $4.7599 (the “pre-funded warrants”) with an equal number of accompanying warrants. The pre-funded warrants had an exercise price per share of Class 2 common stock of $0.0001 and were exercisable at any time after their original issuance and expire on the fifth anniversary date of issuance. As of September 30, 2020, all pre-funded warrants have been exercised. The 19,000,000 total accompanying warrants (the “warrants”) allow the holders to purchase an aggregate of 19,000,000 shares of the Company’s Class 2 common stock. The warrants have an exercise price per share of Class 2 common stock of $5.95 and are exercisable at any time after the first trading day following the six-month anniversary of the issuance and will expire on the fifth anniversary date from the date they become exercisable. As of September 30, 2020, the warrants remain outstanding.

The total gross proceeds of the registered offering were $90,439, of which $21,025 was allocated to the Class 2 common stock at the offering close and $69,414 was allocated to the warrant liability. Issuance costs incurred on the registered offering were $5,150, of which $3,953 was recorded to other expenses (income) in the statements of net loss and comprehensive loss and $1,197 was allocated to the Class 2 common stock and recorded net against the allocated gross proceeds in additional paid-in-capital.

The warrants contain anti-dilution price protection features, which adjust the exercise price of the warrants if the Company subsequently issues Class 2 common stock at a price lower than the exercise price of the warrants. In the event additional warrants or convertible debt are issued with a lower and/or variable exercise price, the exercise price of the warrants will be adjusted accordingly. There were no triggering events during the three and nine months ended September 30, 2020. The Company received stockholder approval of the anti-dilution price protection feature at the Company’s Annual Meeting on May 28, 2020.

The Company's warrants are classified as liabilities as they are to be settled in registered shares, and the registration statement is required to be active, unless such shares may be subject to an applicable exemption from registration requirements. The holders, at their sole discretion, may elect to effect a cashless exercise, and be issued exempt securities in accordance with Section 3(a)(9) of the 1933 Act. In the event the Company does not maintain an effective registration statement, the Company may be required to pay a daily cash penalty equal to 1% of the number of shares of Class 2 common stock due to be issued multiplied by any trading price of the Class 2 common stock between the exercise date and the share delivery date, as selected by the holder. Alternatively, the Company may deliver registered Class 2 common stock purchased by the Company in the open market. The Company may also be required to pay cash if it does not have sufficient authorized shares to deliver to the holders upon exercise.

Pre-funded warrants and warrants outstanding at September 30, 2020, and related activity for the nine months ended September 30, 2020 is as follows (reflects the number of shares of Class 2 common stock as if the warrants were converted to Class 2 common stock):

Description	Classification	Exercise price		Expiration date	Balance December 31, 2019		Issued		Exercised			Balance September 30, 2020
Pre-Funded Warrants	Liability	$	0.0001	March 17, 2025		—		11,750,000		(11,750,000	)		—
Warrants	Liability	$	5.95	March 17, 2025		—		19,000,000		—			19,000,000
				Total		—		30,750,000		(11,750,000	)		19,000,000

The Company estimated the fair value of the Warrant liability at September 30, 2020 at $3.76 per warrant using the Monte Carlo pricing model (Level 3) with the following weighted-average assumptions:

Risk-free interest rate		0.35	%
Expected volatility		100	%
Expected term	5 years
Expected dividend yield		0	%
Strike price	$	5.95
Fair value of common stock	$	4.85

Expected volatility is based on the historical volatility of the Company's common stock since its initial public offering in 2018.

Stockholders' Equity

9 Months Ended

Sep. 30, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stockholders' Equity

15.	Stockholders’ Equity

Common and preferred stock

The Company’s certificate of incorporation authorized the Company to issue the following classes of shares with the following par value and voting rights as of September 30, 2020. The liquidation and dividend rights are identical among Class 1 common stock and Class 2 common stock, and all classes of common stock share equally in the Company’s earnings and losses.

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		233,333,333	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Preferred stock	$	0.0001		10,000,000	N/A

On March 17, 2020, the Company closed the registered offering, issuing 7,250,000 shares of the Company’s Class 2 common stock along with pre-funded warrants and warrants (refer to Note 14). During the period from the close of the registered offering and March 31, 2020, all pre-funded warrants were exercised at a price per share of $0.0001 and the Company issued 11,750,000 shares of Class 2 common stock (refer to Note 14).

During the three and nine months ended September 30, 2020, the Company issued 6,781,090 and 9,493,494 shares of Class 2 common stock for gross proceeds of $46,153 and $76,999, respectively, under the at-the-market equity offering. Transaction costs of $1,540 were recorded net against the allocated gross proceeds in additional paid-in-capital. The warrants’ anti-dilution price protection features allow, for the period the warrants are outstanding, the Company to only issue up to $20,000 in aggregate gross proceeds under the Company’s at-the-market offering program at prices less than the exercise price of the warrants, and in no event more than $6,000 per quarter, at prices below the exercise price of the warrants, without triggering the warrant’s anti-dilution price protection features.

The Company’s future ability to pay cash dividends on Class 2 common stock is limited by the terms of the Senior Facility and cannot be paid without the consent of the lender.

On September 30, 2020, 13,159,762 shares of Class 1 common stock, constituting all of the shares of Class 1 common stock that were issued and outstanding, were automatically converted into shares of Class 2 common stock, as the Class 1 common stock ceased to represent at least 10% of the outstanding common stock. Prior to the conversion, the Company had authorized 250,000,000 shares of Class 1 common stock. Upon conversion, 16,666,667 were retired, leaving 233,333,333 shares authorized, par value $0.0001 per share. There are no shares of Class 1 common stock outstanding as of September 30, 2020.

Stock-Based Compensation

9 Months Ended

Sep. 30, 2020

Stock-Based Compensation

16.	Stock-based Compensation

Original Stock Option Plan

Certain employees of the Company participated in the equity-based compensation plan of Privateer Holdings, Inc. (the “Original Plan”) under the terms and valuation method detailed in the Company’s annual financial statements. For the three and nine months ended September 30, 2020, the total stock-based compensation expense associated with the Original Plan was $114 and $410 (2019 – $143 and $411). As of September 30, 2020, the total remaining unrecognized stock-based compensation expense related to non-vested stock options under the Original Plan amounted to $375 which will be recognized over the weighted-average remaining requisite service period of approximately 0.8 years.

Stock option activity under the Original Plan is as follows:

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		3,014,004		$	3.04		5.8	$	44,108
Exercised		(528,261	)		1.15
Forfeited		(62,153	)		4.44
Cancelled		(125,999	)		3.30
Balance September 30, 2020		2,297,591		$	3.38		3.8	$	32,717
Vested and expected to vest, September 30, 2020		2,299,283		$	3.37		3.8	$	32,742
Vested and exercisable, September 30, 2020		2,198,632		$	3.22		3.7	$	31,750

No stock options were granted under the Original Plan during the nine months ended September 30, 2020 and September 30, 2019. The total fair value of stock options vested as of September 30, 2020 was $118 (December 31, 2019 – $2,789).

New Stock Option and Restricted Stock Unit Plan

The number of shares of Class 2 common stock reserved for issuance under the 2018 Equity Incentive Plan (the “2018 EIP”) automatically increases on January 1 of each calendar year, for a period of not more than ten years, starting on January 1, 2019 and ending on and including January 1, 2027, in an amount equal to 4% of the total number of shares of the Company’s common stock

outstanding on December 31 of the prior calendar year, or a lesser number of shares determined by the Company’s Board of Directors. The shares reserved include only the outstanding shares related to stock options and RSUs and excludes stock options outstanding under the Original Plan. The number of shares reserved for issuance under the 2018 EIP is 17,037,421, effective as of January 1, 2020 (December 31, 2019 – 12,926,172). For the three and nine months ended September 30, 2020, total stock-based compensation expense associated with the 2018 EIP was $7,966 and $22,994 (2019 - $8,501 and $21,892). As of September 30, 2020, the total remaining unrecognized stock-based compensation expense related to non-vested stock options and restricted stock units (“RSUs”) under the 2018 EIP amounted to $40,805 which will be recognized over the weighted average remaining requisite service period of approximately 1.03 years.

Stock option and RSU activity under the 2018 EIP are as follows:

Time-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		5,307,130		$	14.04		8.4	$	44,297
Granted		—			—
Exercised		(286,948	)		7.76
Forfeited		(245,222	)		13.93
Cancelled		(193,127	)		13.11
Balance September 30, 2020		4,581,833		$	14.48		7.6	$	—
Vested and expected to vest, September 30, 2020		4,511,481		$	14.32		7.5	$	—
Vested and exercisable, September 30, 2020		3,276,183		$	12.47		7.6	$	—

During the nine months ended September 30, 2020, no time-based stock options were granted under the 2018 EIP (2019 – 10,000). The weighted-average fair values of stock options granted during the nine months ended September 30, 2020 was $0 per share (2019 – $12.01). The total fair value of stock options vested as of September 30, 2020 was $31,299 (December 31, 2019 – $16,708).

Performance-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		520,000		$	7.76		8.4	$	4,872
Granted		—			—				—
Exercised		(320,000	)		7.76
Forfeited		—			—				—
Cancelled		—			—				—
Balance September 30, 2020		200,000		$	7.76		7.6	$	—
Vested and expected to vest, September 30, 2020		200,000		$	7.76		7.6	$	—
Vested and exercisable, September 30, 2020		200,000		$	7.76		7.6	$	—

No performance-based stock options were granted under the 2018 EIP during the nine months ended September 30, 2020 and September 30, 2019. The total fair value of stock options vested as of September 30, 2020 was $0 (December 31, 2019– $1,246).

Time-based RSU activity

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2019		1,423,392		$	42.05
Granted		2,024,334			8.67
Vested		(396,051	)		45.32
Forfeited		(785,641	)		27.88
Cancelled		(17,711	)		31.31
Non-vested September 30, 2020		2,248,323		$	16.46

During the nine months ended September 30, 2020, 2,024,334 (2019 – 944,616) time-based RSUs were granted. During the nine months ended September 30, 2020, 396,051 (2019 – 54,635) time-based RSUs vested.

Performance-based RSUs activity

	Performance-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2019		265,625		$	7.76
Granted		448,230			7.05
Vested		(159,375	)		7.76
Non-vested September 30, 2020		554,480		$	7.19

448,230 performance-based RSUs were granted during the nine months ended September 30, 2020 (2019 – none). During the nine months ended September 30, 2020, 159,375 (2019 – 731,250) performance-based RSUs vested.

Accumulated Other Comprehensive Income (Loss) (AOCI)

9 Months Ended

Sep. 30, 2020

Accumulated Other Comprehensive Income (Loss) (AOCI)

17.	Accumulated Other Comprehensive Income (Loss) (“AOCI”)

The components of AOCI, net of tax, were as follows:

	Foreign Currency Translation Adjustments			Unrealized (loss) gain on available-for-sale debt securities			Total
Balance as at December 31, 2019	$	10,021		$	(302	)	$	9,719
Other comprehensive loss:
Change in foreign currency translation		(16,633	)		—			(16,633	)
Change in unrealized (losses)/ gains on available-for-sale debt securities		—			(74	)		(74	)
Balance as at March 31, 2020	$	(6,612	)	$	(376	)	$	(6,988	)
Other comprehensive loss:
Change in foreign currency translation		7,184			—			7,184
Change in unrealized gains on available-for-sale debt securities		—			35			35
Balance as at June 30, 2020	$	572		$	(341	)	$	231
Other comprehensive loss:
Change in foreign currency translation		2,265			—			2,265
Change in unrealized gains on available-for-sale debt securities		—			193			193
Balance as at September 30, 2020	$	2,837		$	(148	)	$	2,689

Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

18.	Commitments and Contingencies

Legal proceedings

In the normal course of business, the Company may become involved in legal disputes regarding various litigation matters. The Company records a loss contingency if the information available indicates that it is probable that a liability has been incurred at the date of the financial statements and the amount of loss can be reasonably estimated. As of September 30, 2020, in the opinion of management, no claims meet the criteria to record a loss contingency.

Lease commitments

The Company leases various facilities, under non-cancelable finance and operating leases, which expire at various dates through September 2027.

Maturities of lease liabilities:

Year ending December 31,	Operating Leases		Finance Leases
2020 (remaining three months)	$	941	$	235
2021		3,576		950
2022		3,019		5,389
2023		2,911		11,128
2024		2,489		—
Thereafter		8,049		—
Total lease payments	$	20,985	$	17,702
Imputed interest		2,175		3,207
Obligations recognized	$	18,810	$	14,495

Purchase commitments

The following table reflects the Company’s future non-cancellable minimum purchase commitments for inventory as of September 30, 2020:

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
Purchase commitments	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—
Total	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—

In 2018, the Company signed an agreement with Rose Lifescience Inc. (“Rose”) for distribution and marketing of product in Quebec in exchange for a minimum fee of $384 per annum for an initial term of five years, and agreed to purchase the lesser of 2,000 Kg per year or 40% of the production of Cannabis at a rate of 115% of cost of goods sold from the Rose facility. In September 2020, the Company signed an amendment to this agreement and the estimated compensation fee is approximately $10,350 through 2023. As there is no firm commision fee commitment, it is excluded from the above schedule. Compensation fee expense is recorded as incurred.

In 2018, the Company entered into a Product and Trademark License Agreement with Docklight LLC, a related party (refer to Note 22), to use certain intellectual property rights in exchange for payment of royalty depending upon specified percentage of licensed product net sales. As the purchase commitment is an undeterminable variable amount, it is excluded from the above schedule.

Other commitments

The Company has payments on the ABG finance liability (refer to Note 11), convertible notes (refer to Note 12) and the Senior Facility (refer to Note 13) as follows:

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
ABG finance liability	$	7,500	$	—	$	1,500	$	1,500	$	1,500	$	1,500	$	1,500
Convertible notes, principal and interest		546,251		5,938		23,750		23,750		492,813		—		—
Senior Facility, principal and interest		55,483		1,268		5,071		49,144		—		—		—
Portugal construction commitments		4,927		4,927
Total	$	614,161	$	12,133	$	30,321	$	74,394	$	494,313	$	1,500	$	1,500

Revenue from Contracts with Customers

9 Months Ended

Sep. 30, 2020

Revenue From Contract With Customer [Abstract]

Revenue from Contract with Customers

19.	Revenue from Contracts with Customers

The Company reports two segments: cannabis and hemp, in accordance with ASC 280 Segment Reporting. The Company generates revenues from the cannabis and hemp segments through contracts with customers, each with a single performance obligation, being the sale of products. The Company determines that revenue information disclosed in business segment information in Note 25 disaggregates revenue into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

For certain long-term arrangements, the Company has performance obligations for goods it has not yet delivered. For these arrangements, the Company does not have a right to bill for the undelivered goods. The Company has determined that any unbilled consideration relates entirely to the value of undelivered goods. Accordingly, the Company has not recognized revenue, and has elected not to disclose amounts, related to these undelivered goods. As of September 30, 2020 and December 31, 2019, other than accounts receivable, net of allowance for credit losses and provision for sales returns, the Company has no contract balances in the balance sheets.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

General And Administrative Expense [Abstract]

General and Administrative Expenses

9 Months Ended

Sep. 30, 2020

General and Administrative Expenses

20.	General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020		2019
Salaries	$	8,323		$	8,637		$	24,365	$	22,289
Other expenses		2,367			4,261			12,803		10,651
Professional fees		1,407			6,051			9,750		12,716
Loss on disposal of property and equipment		457			—			885		112
Travel expenses		132			1,448			939		3,330
Credit loss (recovery) expenses		(21	)		(275	)		288		520
Total	$	12,665		$	20,122		$	49,030	$	49,618

Supplemental Cash Flow Information

9 Months Ended

Sep. 30, 2020

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information

21.	Supplemental Cash Flow Information

	Nine months ended September 30,
	2020		2019
Cash paid for interest	$	10,367	$	17,613
Cash paid for income taxes	$	272	$	—
Non-cash investing
Acquisition of Manitoba Harvest	$	—	$	157,917
Acquisition of Natura	$	—	$	38,980
Investment in ABG Profit Participation Arrangement, net of receivable	$	—	$	94,805
Purchases of investments and S&S acquisition	$	—	$	14,508

	Nine months ended September 30,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,672	$	1,524
Operating cash flows from finance leases	$	445	$	—
Financing cash flows from finance leases	$	309	$	—
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases	$	423	$	14,897
Finance leases	$	—	$	—

Related Party Transactions

9 Months Ended

Sep. 30, 2020

Related Party Transactions

22.	Related Party Transactions

In the normal course of business, the Company enters into related party transactions with certain entities under common control and joint ventures as described in the Annual Financial Statements and detailed below.

Leafly Holdings, Inc. (“Leafly”)

The Company has an agreement with Leafly providing for data licensing activities. During the three and nine months ended September 30, 2020, operational expenses of $5 and $134 was recorded within general and administrative expenses in the statements of net loss and comprehensive loss (2019 - $130 and $149).

Docklight LLC (“Docklight”)

The Company pays Docklight a royalty fee pursuant to a brand licensing agreement which provides the Company with exclusive rights in Canada for the use of certain adult-use brands. During the three and nine months ended September 30, 2020, royalty fees of $331 and $748 were recorded within general and administrative expenses in the statements of net loss and comprehensive loss (2019 - $44 and $176). Refer to Note 18 for purchase commitments with Docklight.

Ten Eleven Management LLC (“Ten Eleven”)

In January 2020, the Company entered into a corporate services agreement with Ten Eleven Management LLC (“Ten Eleven”), pursuant to which Ten Eleven provides the Company with certain general administrative and corporate services for a service fee. This agreement was terminated in April 2020. In August 2020, the Company entered into a corporate services agreement with Ten Eleven pursuant to which Ten Eleven provides the Company with certain accounting services for a service fee. This agreement was terminated in October 2020. During the three and nine months ended September 30, 2020, management services of $- and $71 was recorded within general and administrative expenses in the statements of net loss and comprehensive loss (2019 - $75 and $200).

The Company sub-leases a portion of certain office space to Ten Eleven. Ten Eleven’s lease payments are based on the pro-rata share of space that they occupy, with annual lease payments of $470. The sub-lease was terminated in May 2020. For the three and nine months ended September 30, 2020, $- and $196 of sublease income is recorded in other income, net (2019 - $115 and $192).

Fluent and Cannfections

The Company has joint venture arrangements with a 50% ownership and voting interest in each of Fluent and Cannfections. Refer to Note 6 for details over transactions with these entities for the nine months ended September 30, 2020.

Aircraft Time Share Reimbursement

The Company had entered into an aircraft time-share agreement and a lease consent and subordination agreement with Brendan Kennedy, our Chief Executive Officer, whereby the Company had access to and use of an aircraft owned by Mr. Kennedy on an as-needed basis for business purposes. Pursuant to this arrangement, the Company reimbursed Mr. Kennedy for certain related aircraft expenses. During the three and nine months ended September 30, 2020, the Company incurred $0 and $261 of fees which is included in general and administrative expenses (2019 – $0 and $0).

Accounts payable due to related parties

At September 30, 2020, the Company has accounts payable due to related parties of $141 (December 31, 2019 - $68).

Financial Instruments

9 Months Ended

Sep. 30, 2020

Investments All Other Investments [Abstract]

Financial Instruments

23.	Financial Instruments

Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company’s cash and cash equivalents and accounts receivable.

The Company’s cash and cash equivalents are deposited in major financial institutions in Canada, Australia, Portugal, Germany and the United States. To date, the Company has not experienced any losses on its cash deposits. Accounts receivable are unsecured and the Company does not require collateral from its customers.

The Company is also exposed to credit risk from the potential default by any of its counterparties on its financial assets.

The Company evaluates the collectability of its accounts receivable and provides an allowance for credit losses as necessary (refer to Note 7).

Due to the uncertainties associated with COVID-19, the Company may be unable to accurately predict the creditworthiness of its counterparties and their ability to meet their obligations. This may result in unforeseen additional credit losses.

Foreign currency risk

The Company conducts its business in several countries and in a variety of currencies, the most significant of which are the Canadian dollar and Euro. Consequently, the Company is exposed to foreign currency risk. A significant portion of the Company’s assets, liabilities, revenue, and expenses are denominated in Canadian dollars. A 10% change in the exchange rates for the Canadian dollar would affect the carrying value of net assets by approximately $23,578 as of September 30, 2020, with a corresponding impact to accumulated other comprehensive income (loss). The Company is also exposed to risk related to changes in the value of the Euro due to its construction commitment in Portugal.

Interest rate risk

The Company’s exposure to changes in interest rates relates primarily to the Company’s outsanding debt. The Company is exposed to changes to the Canadian prime rate as the Senior Facility bears interest based on the Canadian prime rate plus 8.05%. The convertible notes bear interest at a fixed rate of 5% and are not publicly traded and, therefore, are not affected by changes in the market interest rates. A 1% change in the Canadian prime rate would have an impact of $127 and $295 to the statements of net loss and comprehensive loss for the three and nine months ended September 30, 2020.

Liquidity risk

The Company’s objective is to have sufficient liquidity to meet its liabilities when due. The Company monitors its cash balances and cash flows generated from operations to meet its requirements. As of September 30, 2020, the most significant financial liabilities are accounts payable, accrued expenses and other current liabilities, convertible notes and the Senior Facility.

Fair Value Measurement

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement

24.	Fair Value Measurement

The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

	Quoted prices
	in active
	markets for		Other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)			Total
As of September 30, 2020
Investments
Equity investments measured at fair value	$	2,207	$	—	$	—		$	2,207
Debt securities classified as available-for-sale		844		—		4,921			5,765
Warrant liability		—		—		(71,636	)		(71,636	)
Total recurring fair value measurements	$	3,051	$	—	$	(66,715	)	$	(63,664	)

	Quoted prices
	in active
	markets for		Other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)			Total
As of December 31, 2019
Investments
Equity investments measured at fair value	$	4,183	$	—	$	—		$	4,183
Debt securities classified as available-for-sale		727		—		4,320			5,047
Acquisition-related contingent consideration		—		—		(420	)		(420	)
Total recurring fair value measurements	$	4,910	$	—	$	3,900		$	8,810

Items measured at fair value on a recurring basis

The Company’s financial assets and liabilities required to be measured on a recurring basis are its equity investments measured at fair value, debt securities classified as available-for-sale, acquisition-related contingent consideration, and warrant liability.

Debt securities classified as available-for-sale and equity investments recorded at fair value: The estimated fair value is determined using quoted market prices, broker or dealer quotations or discounted cash flows.

Warrant liability: The warrants associated with the warrant liability are classified as Level 3 derivatives. Consequently, the estimated fair value of the warrant liability is determined using the Monte Carlo pricing model (refer to Note 14). Until the warrants are exercised, expire, or other facts and circumstances lead the warrant liability to be reclassified to stockholders’ equity, the warrant liability (which relates to warrants to purchase shares of Class 2 common stock) is marked-to-market each reporting period with the change in fair value recorded in change in fair value of warrant liability,. Any significant adjustments to the unobservable inputs disclosed in the table below would have a direct impact on the fair value of the warrant liability.

The opening balances of assets and liabilities categorized within Level 3 of the fair value hierarchy measured at fair value on a recurring basis are reconciled to the closing balances as follows:

	Debt securities classified as available-for- sale		Warrant liability
Opening balance as at December 31, 2019	$	4,320	$	—
Additions and settlements
Additions		—		(69,414	)
Exercise		—		49,053
Total gains or losses for the period:		—		—
Included in net loss		—		—
Interest expenses, net		601		—
Change in fair value of warrant liability		—		(51,275	)
Impairment of assets		—		—
Foreign currency translation loss, net		—		—
Closing balance as at September 30, 2020	$	4,921	$	(71,636	)

Quantitative information about Level 3 fair value measurements

Fair value at September 30, 2020

Valuation technique

Unobservable input

Range (weighted average)

Discount rate

16.5%

Debt securities classified as available-for-sale

4,921

Discounted cash flow

Probability of conversion/ prepayment

nil

Probability of default

nil

Warrant liability

(71,636

)

Monte Carlo

Volatility

100%

Expected life

0.2 years to 5 years (2.4 years)

Items measured at fair value on a non-recurring basis

The Company's prepayments and other current assets, long lived assets, including property and equipment, goodwill and intangible assets are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized.

Land and buildings (held for sale): The Company used a third-party real estate agent to assist management in its determination of the fair value of the assets held for sale at the High Park Gardens facility. Management, in its determination of the fair value of the assets held for sale reviewed market data from recent sales of similar properties to determine an implied sale price per acre of land and greenhouse space and wrote-down the carrying value of the land and greenhouse space held for sale to the estimated fair value less selling costs.

In connection with an evaluation of such assets during the nine months ended September 30, 2020, the carrying values of the land and buildings at the High Park Gardens facility (Level 2), ABG finance receivable and certain intangible assets (Level 3) were concluded to exceed their fair values. As a result, the Company recorded impairment charges that incorporates fair value measurements based on Level 2 (refer to Note 2) and Level 3 inputs (refer to Note 3, Note 8 and Note 10).

The estimated fair value of cash and cash equivalents, accounts receivable, net, accounts payable, accrued expenses and other current liabilities, convertible notes and Senior Facility at September 30, 2020 (December 31, 2019 – the fair value of all aforementioned, except the Senior Facility which was entered into in 2020) approximate their carrying value.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Business Segment Information

Business Segment Information

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

25.	Business Segment Information

The Company has two operating segments based on major product categories: cannabis and hemp. These operating segments are also the Company’s reportable segments.

The cannabis segment cultivates, processes and distributes medical and adult-use cannabis products in a variety of formats, as well as related accessories, on a global basis. The hemp segment processes and distributes a diverse portfolio of hemp-based natural and organic food and wellness products on a global basis.

The results of each segment are regularly reviewed by the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, to assess the performance of the segment and make decisions regarding the allocation of resources. The Company’s chief operating decision maker uses revenue and gross profit as the measure of segment profit or loss. The accounting policies of each segment are the same as those set out under the summary of significant accounting policies in Note 1. There are no intersegment sales or transfers.

The comparative three and nine months ended September 30, 2019 have been recast to reflect to the current segment structure.

	Three months ended September 30,									Nine months ended September 30,
	2020					2019				2020					2019
	Revenue		Gross profit / (loss)			Revenue		Gross profit		Revenue		Gross profit / (loss)			Revenue		Gross profit
Cannabis	$	31,426	$	(4,717	)	$	35,451	$	9,225	$	92,373	$	(13,863	)	$	78,876	$	16,213
Hemp	$	19,980	$	8,456		$	15,650	$	6,628	$	61,549	$	23,053		$	41,167	$	17,298
Total	$	51,406	$	3,739		$	51,101	$	15,853	$	153,922	$	9,190		$	120,043	$	33,511

No asset information is provided for the segments because the Company’s chief operating decision maker does not review this information by segment on a regular basis.

Total revenue and gross profit for the reportable segments is equal to the Company’s consolidated revenue and gross profit.

	Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020			2019
Gross profit for the segments	$	3,739		$	15,853		$	9,190		$	33,511
General and administrative expenses		12,665			20,122			49,030			49,618
Sales and marketing expenses		10,000			16,974			40,709			39,161
Research and development expenses		921			2,315			2,831			4,891
Depreciation and amortization expenses		3,425			3,200			10,353			7,457
Stock-based compensation expenses		8,080			8,644			23,404			22,303
Impairment of assets		—			—			58,210			—
Acquisition-related expenses (income), net		—			(13,454	)		—			(6,566	)
Loss from equity method investments		1,420			1,837			4,495			1,837
Foreign exchange (gain) loss, net		(9,319	)		2,585			5,424			1,153
Change in fair value of warrant liability		(31,913	)		—			51,275			—
Interest expenses, net		10,437			8,680			30,147			26,005
Finance income from ABG		—			(210	)		—			(557	)
Other expense (income), net		(38	)		(1,116	)		4,944			(6,185	)
Loss before income taxes	$	(1,939	)	$	(33,724	)	$	(271,632	)	$	(105,606	)

Sources of revenue were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Dried cannabis	$	21,079	$	29,412	$	61,339	$	62,214
Cannabis extracts		10,239		5,819		30,246		16,172
Hemp products		19,980		15,650		61,549		41,167
Accessories and other		108		220		788		490
Total	$	51,406	$	51,101	$	153,922	$	120,043

Channels of revenue were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Cannabis
Adult-use	$	19,926	$	15,835	$	58,466	$	38,758
Canada - medical		3,399		3,898		11,285		9,222
International - medical		8,101		5,708		22,220		9,370
Bulk		—		10,010		402		21,526
Total Cannabis revenue	$	31,426	$	35,451	$	92,373	$	78,876
Hemp		19,980		15,650		61,549		41,167
Total	$	51,406	$	51,101	$	153,922	$	120,043

Revenue attributed to geographic region based on the location of the customer was as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Canada	$	29,475	$	33,585	$	86,807	$	81,138
United States		13,340		10,836		43,851		28,407
Other countries		8,591		6,680		23,264		10,498
Total	$	51,406	$	51,101	$	153,922	$	120,043

Revenue includes excise duties of $4,213 and $13,325 for the three and nine months ended September 30, 2020 (2019: $2,931 and $8,707).

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	September 30, 2020		December 31, 2019
Canada	$	115,711	$	144,065
Portugal		67,198		36,908
United States		4,659		3,171
Other countries		62		73
Total	$	187,630	$	184,217

Two customers accounted for 21% and 19% of revenue, respectively, for the three months ended September 30, 2020. Three customers accounted for 20%, 18% and 11% of revenue, respectively, for the nine months ended September 30, 2020. Three customers accounted for 20%, 14%, and 10% of revenue, respectively, for the three months ended September 30, 2019. Two customers accounted for 12% and 11%, of revenue, respectively, for the nine months ended September 30, 2019.

Two customers accounted for 20% and 11%, respectively, of the Company’s accounts receivable balance, as of September 30, 2020. Two customers accounted for 20% and 10%, respectively, of the Company’s accounts receivable balance as of December 31, 2019.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

Description of the Business

Subsequent Events

9 Months Ended

Sep. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

26.	Subsequent Events

As of September 30, 2020, Tilray holds 8,532,243 shares of stock in Kiaro Brands Inc. (Kiaro) at a balance of $3,600 within Other Investments. Effective October 13, 2020, Kiaro went public as Kiaro Holdings Corp. (Ticker: KO) on the TSX Venture Exchange at a price of CAD $0.17 per share. The completion of this transaction will impact the manner the Company assesses the fair value reporting of its investment, which will continue to be presented within Other Investments.

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Description of the business

Basis of Presentation and Going Concern

Basis of presentation and going concern

As at September 30, 2020 and December 31, 2019 the Company had working capital of $171,349 and $166,600, respectively.

Changes in comparative presentation

	Three months ended September 30, 2019						Nine months ended September 30, 2019
	Net loss			Other comprehensive (loss) income			Net (loss) income			Other comprehensive (loss) income
Unadjusted	$	(35,678	)	$	(5,164	)	$	(101,032	)	$	(2,069	)
Impact of adoption of accounting standards:
ASU 2016-01		(312	)		312			265			(265	)
ASC 842		(32	)		—			(157	)		—
ASU 2018-07		(329	)		—			(1,097	)		—
ASC 606		—			—			—			—
Adjusted	$	(36,351	)	$	(4,852	)	$	(102,021	)	$	(2,334	)

Assets Held for Sale

Assets held for sale

Assets classified as held for sale are combined and presented separately from the other assets in the balance sheets.

Allowance for Credit Losses

Allowance for credit losses

Disclosure Framework - Fair Value Measurement

Disclosure framework - fair value measurement

Warrants

Use of Estimates and Significant Judgements

Use of estimates and significant judgements

Net Loss Per Share

Net loss per share

New Accounting Pronouncements Not Yet Adopted

New accounting pronouncements not yet adopted

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Summary of Impact to Statements of Net Loss and Comprehensive Loss

The impact to the statements of net loss and comprehensive loss for the three and nine months ended September 30, 2019 is as follows:

	Three months ended September 30, 2019						Nine months ended September 30, 2019
	Net loss			Other comprehensive (loss) income			Net (loss) income			Other comprehensive (loss) income
Unadjusted	$	(35,678	)	$	(5,164	)	$	(101,032	)	$	(2,069	)
Impact of adoption of accounting standards:
ASU 2016-01		(312	)		312			265			(265	)
ASC 842		(32	)		—			(157	)		—
ASU 2018-07		(329	)		—			(1,097	)		—
ASC 606		—			—			—			—
Adjusted	$	(36,351	)	$	(4,852	)	$	(102,021	)	$	(2,334	)

Assets Held for Sale (Tables)

9 Months Ended

Sep. 30, 2020

Assets Of Disposal Group Including Discontinued Operation [Abstract]

Summary of Assets Comprising Disposal Group Classified as Held for Sale

The carrying amount of major classes of assets comprising the disposal group classified as held for sale are as follows:

	As of September 30, 2020
Assets classified as held for sale
Land and buildings	$	6,797
Cultivation license		—
Total assets held for sale	$	6,797

Summary of Pretax (Loss) Income Continuing Operations

The following table provides summary pretax (loss) income for the High Park Gardens facility, which are included in continuing operations for their respective periods:

	Three months ended September 30,					Nine months ended September 30,
	2020			2019		2020			2019
Pre-tax (loss) income	$	(642	)	$	119	$	(28,335	)	$	(396	)

Inventory (Tables)

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory is comprised of the following items:

	September 30, 2020		December 31, 2019
Raw materials	$	15,338	$	15,926
Work-in-process		59,863		53,973
Finished goods		14,716		17,962
Total	$	89,917	$	87,861

Schedule of Inventory Valuation Adjustments Included in Cost of Sales

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Raw materials	$	173	$	—	$	384	$	—
Work-in-process		11,164		201		30,656		726
Finished goods		2,106		—		5,076		—
Total	$	13,443	$	201	$	36,116	$	726

Prepayments and Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2020

Prepaid Expense And Other Assets Current [Abstract]

Schedule of Prepayments and Other Current Assets

Prepayments and other current assets are comprised of the following items:

	September 30, 2020		December 31, 2019
Deposits	$	15,325	$	25,490
Prepayments		6,854		5,847
Taxes receivable		5,975		6,165
ABG finance receivable - current		—		671
Total	$	28,154	$	38,173

Investments (Tables)

9 Months Ended

Sep. 30, 2020

Investments Debt And Equity Securities [Abstract]

Summary of Long-term Investments

Long-term investments are comprised of the following items:

	September 30, 2020		December 31, 2019
Equity investments at fair value	$	2,207	$	4,183
Equity investments under measurement alternative		14,738		14,954
Debt securities classified under available-for-sale method		5,765		5,047
Total other investments	$	22,710	$	24,184

Summary of Ownership Interests in Equity Method Investments

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	September 30, 2020		September 30, 2020
Investment in Fluent	50%	$	5,147	$	(4,725	)
Investment in Cannfections	50%		3,764		230
Total equity method investments		$	8,911	$	(4,495	)

	Approximate	Carrying value		(Loss) gain from equity method investments for the nine months ended
	ownership %	December 31, 2019		September 30, 2019
Investment in Fluent	50%	$	7,836	$	(1,837	)
Investment in Cannfections	50%		3,612		—
Total equity method investments		$	11,448	$	(1,837	)

Summary of Financial Information for Equity Method Investments

Summary financial information for the Company’s equity method investments on an aggregate basis is as follows:

	September 30, 2020		December 31, 2019
Current assets	$	12,346	$	13,942
Noncurrent assets	$	5,205	$	4,987
Current liabilities	$	4,965	$	1,561
Noncurrent liabilities	$	—	$	—

	Nine months ended September 30,
	2020			2019
Revenue	$	4,854		$	—
Gross profit	$	2,032		$	—
Net loss	$	(8,991	)	$	(3,160	)

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Allowance For Credit Loss [Abstract]

Allowance for Credit Losses (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Allowance for Credit Losses

The following table provides activity in the allowance for credit losses for the nine months ended September 30, 2020:


Allowance for credit losses, January 1, 2020	$	615
Provision for expected credit losses ⁽¹⁾		288
Write-offs charged against allowance		(74	)
Recoveries of amounts previously written off		—
Foreign currency translation adjustment		(3	)
Allowance for credit losses, September 30, 2020	$	826
Accounts receivable balance before allowance for credit losses and provision for sales returns, September 30, 2020	$	26,843

(1)	The provision for expected credit losses is recorded in general and administrative expenses.

Schedule of Fair Value and Unrealized Loss of Investment

The following table provides the fair value and unrealized loss of the investment at September 30, 2020 and December 31, 2019:

	September 30, 2020		December 31, 2019
Fair value	$	1,124	$	945
Unrealized loss	$	148	$	302

Property and Equipment, Net (Tables)

9 Months Ended

Sep. 30, 2020

Property Plant And Equipment [Abstract]

Summary of Property and Equipment

Property and equipment, net consists of the following:

	September 30, 2020			December 31, 2019
Land	$	6,488		$	6,417
Buildings and leasehold improvements		108,021			109,172
Laboratory and manufacturing equipment		34,500			31,173
Office and computer equipment		1,779			2,659
Right-of-use assets under finance lease		14,415			14,753
Construction-in-process, not yet available for use		46,551			37,160
		211,754			201,334
Less: accumulated depreciation		(24,124	)		(17,117	)
Total	$	187,630		$	184,217

Goodwill (Tables)

9 Months Ended

Sep. 30, 2020

Goodwill Disclosure [Abstract]

Schedule of Change in Carrying Amount of Goodwill

The following table shows the change in carrying amount of goodwill:

	Hemp			Cannabis			Total
Balance as of December 31, 2019	$	133,314		$	29,937		$	163,251
Foreign currency translation adjustment		(2,971	)		(685	)		(3,656	)
Balance as of September 30, 2020	$	130,343		$	29,252		$	159,595

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2020

Intangible Assets Net Excluding Goodwill [Abstract]

Schedule of Intangible Assets

Intangible assets are comprised of the following items:

	September 30,								December 31,
	2020								2019
	Cost		Accumulated Amortization		Impairment		Net		Cost		Accumulated Amortization		Impairment		Net
Definite-lived intangible assets:
Patent	$	669	$	131	$	538	$	—	$	716	$	99	$	—	$	617
Customer relationships		132,837		13,241		—		119,596		135,953		7,132		—		128,821
Developed technology		6,912		1,094		—		5,818		7,074		590		—		6,484
Websites		5,126		3,921		—		1,205		5,157		3,331		—		1,826
Trademarks and licenses		9,052		1,293		7,650		109		9,135		925		—		8,210
Total		154,596		19,680		8,188		126,728		158,035		12,077		—		145,958
Indefinite-lived intangible assets:
Cultivation license		10,239		—		10,239		—		10,689		—		—		10,689
Alef license		—		—		—		—		4,086		—		4,086		—
Trademarks		54,125		—		—		54,125		55,416		—		—		55,416
Rights under ABG Profit Participation Arrangement		16,765		—		16,765		—		119,366		—		102,601		16,765
Total		81,129		—		27,004		54,125		189,557		—		106,687		82,870
Total intangible assets		235,725		19,680		35,192		180,853	$	347,592	$	12,077	$	106,687	$	228,828

Schedule of Future Amortization Expenses for Intangible Assets

Year ending December 31,	Amortization
2020 (remaining three months)	$	2,522
2021		9,801
2022		9,306
2023		9,078
2024		9,078
Thereafter		86,943
Total	$	126,728

Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2020

Payables And Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following items:

	September 30, 2020		December 31, 2019
Accrued interest on convertible notes	$	11,875	$	5,938
Accrued payroll and employment related withholding taxes		10,709		24,765
Other accrued expenses and current liabilities		8,031		17,032
ABG finance liability - current		1,125		1,500
Accrued interest on Senior Facility		422		—
Accrued legal and professional fees		364		1,174
Contingent consideration for acquisitions		—		420
Total accrued expenses and other current liabilities	$	32,526	$	50,829

Schedule of Reconciliation of Severance Costs Within Accrued Payroll Related to Scheduled Benefit Payments

The following table shows the reconciliation of the severance costs included within the accrued payroll and employment related withholding taxes balance above, relating to scheduled benefit payments which were communicated to employees prior to September 30, 2020:


Opening Balance as of January 1, 2020	$	—
Additional charges		3,575
Less payments made to employees		(3,393	)
Closing Balance as of September 30, 2020	$	182

Convertible Notes (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Schedule of Components of Net Carrying Amount of Convertible Notes

The following table sets forth the net carrying amount of the convertible notes:

	September 30, 2020			December 31, 2019
5.00% Convertible Notes	$	475,000		$	475,000
Unamortized discount		(28,133	)		(34,219	)
Unamortized transaction costs		(8,713	)		(10,571	)
Net carrying amount	$	438,154		$	430,210

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the convertible notes:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Contractual coupon interest	$	5,938	$	5,938	$	17,813	$	17,813
Amortization of discount		2,059		1,969		6,087		5,790
Amortization of transaction costs		641		614		1,857		1,826
Total	$	8,638	$	8,521	$	25,757	$	25,429

Senior Facility (Tables)

9 Months Ended

Sep. 30, 2020

Debt Instrument [Line Items]

Schedule of Components of Net Carrying Amount of Senior Facility

The following table sets forth the net carrying amount of the Senior Facility:

	September 30, 2020
Senior Facility	$	48,299
Unamortized transaction costs		(2,355	)
Net carrying amount	$	45,944
Less: current portion of Senior Facility		—
Total noncurrent portion of Senior Facility	$	45,944

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the convertible notes:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Contractual coupon interest	$	5,938	$	5,938	$	17,813	$	17,813
Amortization of discount		2,059		1,969		6,087		5,790
Amortization of transaction costs		641		614		1,857		1,826
Total	$	8,638	$	8,521	$	25,757	$	25,429

Senior Secured Term Loan Facility [Member]

Debt Instrument [Line Items]

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the Senior Facility:

	Three months ended September 30, 2020		Nine months ended September 30, 2020
Contractual interest at Canadian prime plus 8.05%	$	1,260	$	2,970
Amortization of transaction costs		407		943
Total	$	1,667	$	3,913

Registered Offering and Warrants (Tables)

9 Months Ended

Sep. 30, 2020

Class Of Stock [Line Items]

Schedule of Pre-funded Warrants and Warrants Outstanding

Description	Classification	Exercise price		Expiration date	Balance December 31, 2019		Issued		Exercised			Balance September 30, 2020
Pre-Funded Warrants	Liability	$	0.0001	March 17, 2025		—		11,750,000		(11,750,000	)		—
Warrants	Liability	$	5.95	March 17, 2025		—		19,000,000		—			19,000,000
				Total		—		30,750,000		(11,750,000	)		19,000,000

Schedule of Estimated Fair Value of Warrant Liability

Quantitative information about Level 3 fair value measurements

Fair value at September 30, 2020

Valuation technique

Unobservable input

Range (weighted average)

Discount rate

16.5%

Debt securities classified as available-for-sale

4,921

Discounted cash flow

Probability of conversion/ prepayment

nil

Probability of default

nil

Warrant liability

(71,636

)

Monte Carlo

Volatility

100%

Expected life

0.2 years to 5 years (2.4 years)

Warrant [Member]

Class Of Stock [Line Items]

Schedule of Estimated Fair Value of Warrant Liability

The Company estimated the fair value of the Warrant liability at September 30, 2020 at $3.76 per warrant using the Monte Carlo pricing model (Level 3) with the following weighted-average assumptions:

Risk-free interest rate		0.35	%
Expected volatility		100	%
Expected term	5 years
Expected dividend yield		0	%
Strike price	$	5.95
Fair value of common stock	$	4.85

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

Summary of Capital Stock

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		233,333,333	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Preferred stock	$	0.0001		10,000,000	N/A

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Original Stock Option Plan [Member]

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Stock Option Activity

Stock option activity under the Original Plan is as follows:

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		3,014,004		$	3.04		5.8	$	44,108
Exercised		(528,261	)		1.15
Forfeited		(62,153	)		4.44
Cancelled		(125,999	)		3.30
Balance September 30, 2020		2,297,591		$	3.38		3.8	$	32,717
Vested and expected to vest, September 30, 2020		2,299,283		$	3.37		3.8	$	32,742
Vested and exercisable, September 30, 2020		2,198,632		$	3.22		3.7	$	31,750

2018 Equity Incentive Plan [Member] | Time-based Stock Options [Member]

Schedule of Stock Option Activity

Time-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		5,307,130		$	14.04		8.4	$	44,297
Granted		—			—
Exercised		(286,948	)		7.76
Forfeited		(245,222	)		13.93
Cancelled		(193,127	)		13.11
Balance September 30, 2020		4,581,833		$	14.48		7.6	$	—
Vested and expected to vest, September 30, 2020		4,511,481		$	14.32		7.5	$	—
Vested and exercisable, September 30, 2020		3,276,183		$	12.47		7.6	$	—

2018 Equity Incentive Plan [Member] | Performance-based Stock Options [Member]

Schedule of Stock Option Activity

Performance-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2019		520,000		$	7.76		8.4	$	4,872
Granted		—			—				—
Exercised		(320,000	)		7.76
Forfeited		—			—				—
Cancelled		—			—				—
Balance September 30, 2020		200,000		$	7.76		7.6	$	—
Vested and expected to vest, September 30, 2020		200,000		$	7.76		7.6	$	—
Vested and exercisable, September 30, 2020		200,000		$	7.76		7.6	$	—

2018 Equity Incentive Plan [Member] | Time-based RSU [Member]

Schedule of RSU Activity

Time-based RSU activity

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2019		1,423,392		$	42.05
Granted		2,024,334			8.67
Vested		(396,051	)		45.32
Forfeited		(785,641	)		27.88
Cancelled		(17,711	)		31.31
Non-vested September 30, 2020		2,248,323		$	16.46

2018 Equity Incentive Plan [Member] | Performance-based RSUs [Member]

Schedule of RSU Activity

Performance-based RSUs activity

	Performance-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2019		265,625		$	7.76
Granted		448,230			7.05
Vested		(159,375	)		7.76
Non-vested September 30, 2020		554,480		$	7.19

Accumulated Other Comprehensive Income (Loss) (AOCI) (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Accumulated Other Comprehensive Income

The components of AOCI, net of tax, were as follows:

	Foreign Currency Translation Adjustments			Unrealized (loss) gain on available-for-sale debt securities			Total
Balance as at December 31, 2019	$	10,021		$	(302	)	$	9,719
Other comprehensive loss:
Change in foreign currency translation		(16,633	)		—			(16,633	)
Change in unrealized (losses)/ gains on available-for-sale debt securities		—			(74	)		(74	)
Balance as at March 31, 2020	$	(6,612	)	$	(376	)	$	(6,988	)
Other comprehensive loss:
Change in foreign currency translation		7,184			—			7,184
Change in unrealized gains on available-for-sale debt securities		—			35			35
Balance as at June 30, 2020	$	572		$	(341	)	$	231
Other comprehensive loss:
Change in foreign currency translation		2,265			—			2,265
Change in unrealized gains on available-for-sale debt securities		—			193			193
Balance as at September 30, 2020	$	2,837		$	(148	)	$	2,689

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2020

Commitments And Contingencies Disclosure [Abstract]

Summary of Maturities of Lease Liabilities

Maturities of lease liabilities:

Year ending December 31,	Operating Leases		Finance Leases
2020 (remaining three months)	$	941	$	235
2021		3,576		950
2022		3,019		5,389
2023		2,911		11,128
2024		2,489		—
Thereafter		8,049		—
Total lease payments	$	20,985	$	17,702
Imputed interest		2,175		3,207
Obligations recognized	$	18,810	$	14,495

Schedule of Future Non-cancellable Minimum Purchase Commitments

The following table reflects the Company’s future non-cancellable minimum purchase commitments for inventory as of September 30, 2020:

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
Purchase commitments	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—
Total	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—

Schedule of Other Commitments Maturities

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
ABG finance liability	$	7,500	$	—	$	1,500	$	1,500	$	1,500	$	1,500	$	1,500
Convertible notes, principal and interest		546,251		5,938		23,750		23,750		492,813		—		—
Senior Facility, principal and interest		55,483		1,268		5,071		49,144		—		—		—
Portugal construction commitments		4,927		4,927
Total	$	614,161	$	12,133	$	30,321	$	74,394	$	494,313	$	1,500	$	1,500

General and Administrative Expenses (Tables)

9 Months Ended

Sep. 30, 2020

General And Administrative Expense [Abstract]

Schedule of General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020		2019
Salaries	$	8,323		$	8,637		$	24,365	$	22,289
Other expenses		2,367			4,261			12,803		10,651
Professional fees		1,407			6,051			9,750		12,716
Loss on disposal of property and equipment		457			—			885		112
Travel expenses		132			1,448			939		3,330
Credit loss (recovery) expenses		(21	)		(275	)		288		520
Total	$	12,665		$	20,122		$	49,030	$	49,618

Supplemental Cash Flow Information (Tables)

9 Months Ended

Sep. 30, 2020

Supplemental Cash Flow Information [Abstract]

Schedule of Supplemental Cash Flow Information

	Nine months ended September 30,
	2020		2019
Cash paid for interest	$	10,367	$	17,613
Cash paid for income taxes	$	272	$	—
Non-cash investing
Acquisition of Manitoba Harvest	$	—	$	157,917
Acquisition of Natura	$	—	$	38,980
Investment in ABG Profit Participation Arrangement, net of receivable	$	—	$	94,805
Purchases of investments and S&S acquisition	$	—	$	14,508

Summary of Supplemental Cash Flow Information Related to Leases

	Nine months ended September 30,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,672	$	1,524
Operating cash flows from finance leases	$	445	$	—
Financing cash flows from finance leases	$	309	$	—
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases	$	423	$	14,897
Finance leases	$	—	$	—

Fair Value Measurement (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Schedule of Assets Measured at Fair Value on Recurring and Non-recurring Basis

	Quoted prices
	in active
	markets for		Other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)			Total
As of September 30, 2020
Investments
Equity investments measured at fair value	$	2,207	$	—	$	—		$	2,207
Debt securities classified as available-for-sale		844		—		4,921			5,765
Warrant liability		—		—		(71,636	)		(71,636	)
Total recurring fair value measurements	$	3,051	$	—	$	(66,715	)	$	(63,664	)

	Quoted prices
	in active
	markets for		Other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)			Total
As of December 31, 2019
Investments
Equity investments measured at fair value	$	4,183	$	—	$	—		$	4,183
Debt securities classified as available-for-sale		727		—		4,320			5,047
Acquisition-related contingent consideration		—		—		(420	)		(420	)
Total recurring fair value measurements	$	4,910	$	—	$	3,900		$	8,810

Schedule of Opening Balances of Assets and Liabilities Categorized Within Level 3 of Fair Value Hierarchy Measured at Fair Value on Recurring Basis are Reconciled to Closing Balances

The opening balances of assets and liabilities categorized within Level 3 of the fair value hierarchy measured at fair value on a recurring basis are reconciled to the closing balances as follows:

	Debt securities classified as available-for- sale		Warrant liability
Opening balance as at December 31, 2019	$	4,320	$	—
Additions and settlements
Additions		—		(69,414	)
Exercise		—		49,053
Total gains or losses for the period:		—		—
Included in net loss		—		—
Interest expenses, net		601		—
Change in fair value of warrant liability		—		(51,275	)
Impairment of assets		—		—
Foreign currency translation loss, net		—		—
Closing balance as at September 30, 2020	$	4,921	$	(71,636	)

Schedule of Estimated Fair Value of Warrant Liability

Quantitative information about Level 3 fair value measurements

Fair value at September 30, 2020

Valuation technique

Unobservable input

Range (weighted average)

Discount rate

16.5%

Debt securities classified as available-for-sale

4,921

Discounted cash flow

Probability of conversion/ prepayment

nil

Probability of default

nil

Warrant liability

(71,636

)

Monte Carlo

Volatility

100%

Expected life

0.2 years to 5 years (2.4 years)

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

Summary of Revenue and Gross Profit

Business Segment Information (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

The comparative three and nine months ended September 30, 2019 have been recast to reflect to the current segment structure.

	Three months ended September 30,									Nine months ended September 30,
	2020					2019				2020					2019
	Revenue		Gross profit / (loss)			Revenue		Gross profit		Revenue		Gross profit / (loss)			Revenue		Gross profit
Cannabis	$	31,426	$	(4,717	)	$	35,451	$	9,225	$	92,373	$	(13,863	)	$	78,876	$	16,213
Hemp	$	19,980	$	8,456		$	15,650	$	6,628	$	61,549	$	23,053		$	41,167	$	17,298
Total	$	51,406	$	3,739		$	51,101	$	15,853	$	153,922	$	9,190		$	120,043	$	33,511

No asset information is provided for the segments because the Company’s chief operating decision maker does not review this information by segment on a regular basis.

Total revenue and gross profit for the reportable segments is equal to the Company’s consolidated revenue and gross profit.

	Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020			2019
Gross profit for the segments	$	3,739		$	15,853		$	9,190		$	33,511
General and administrative expenses		12,665			20,122			49,030			49,618
Sales and marketing expenses		10,000			16,974			40,709			39,161
Research and development expenses		921			2,315			2,831			4,891
Depreciation and amortization expenses		3,425			3,200			10,353			7,457
Stock-based compensation expenses		8,080			8,644			23,404			22,303
Impairment of assets		—			—			58,210			—
Acquisition-related expenses (income), net		—			(13,454	)		—			(6,566	)
Loss from equity method investments		1,420			1,837			4,495			1,837
Foreign exchange (gain) loss, net		(9,319	)		2,585			5,424			1,153
Change in fair value of warrant liability		(31,913	)		—			51,275			—
Interest expenses, net		10,437			8,680			30,147			26,005
Finance income from ABG		—			(210	)		—			(557	)
Other expense (income), net		(38	)		(1,116	)		4,944			(6,185	)
Loss before income taxes	$	(1,939	)	$	(33,724	)	$	(271,632	)	$	(105,606	)

Sources of revenue were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Dried cannabis	$	21,079	$	29,412	$	61,339	$	62,214
Cannabis extracts		10,239		5,819		30,246		16,172
Hemp products		19,980		15,650		61,549		41,167
Accessories and other		108		220		788		490
Total	$	51,406	$	51,101	$	153,922	$	120,043

Channels of revenue were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Cannabis
Adult-use	$	19,926	$	15,835	$	58,466	$	38,758
Canada - medical		3,399		3,898		11,285		9,222
International - medical		8,101		5,708		22,220		9,370
Bulk		—		10,010		402		21,526
Total Cannabis revenue	$	31,426	$	35,451	$	92,373	$	78,876
Hemp		19,980		15,650		61,549		41,167
Total	$	51,406	$	51,101	$	153,922	$	120,043

Summary of Revenue Attributed to a Geographic Region Based on the Location of the Customer

Revenue attributed to geographic region based on the location of the customer was as follows:

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Canada	$	29,475	$	33,585	$	86,807	$	81,138
United States		13,340		10,836		43,851		28,407
Other countries		8,591		6,680		23,264		10,498
Total	$	51,406	$	51,101	$	153,922	$	120,043

Summary of Long-lived Assets Consisting of Property and Equipment, Net of Accumulated Depreciation, Attributed to Geographic Regions Based on their Physical Location

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	September 30, 2020		December 31, 2019
Canada	$	115,711	$	144,065
Portugal		67,198		36,908
United States		4,659		3,171
Other countries		62		73
Total	$	187,630	$	184,217

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)		3 Months Ended						9 Months Ended
	Mar. 17, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Feb. 28, 2020	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Net loss		$ (2,316,000)	$ (81,687,000)	$ (184,123,000)	$ (36,351,000)	$ (36,301,000)	$ (29,369,000)	$ (268,124,000)	$ (102,021,000)
Net cash used in operating activities								(104,486,000)	$ (167,255,000)
Working capital		171,349,000						171,349,000			$ 166,600,000
Proceeds from issuance of registered offering, net of issuance costs	$ 85,289,000							$ 85,465,000
Proceeds from registered equity offering, gross	$ 90,439,000	$ 46,153,000
Warrants issued	19,000,000
Warrants outstanding		19,000,000						19,000,000
Maximum allowed aggregate gross proceeds from share issuance under ATM program								$ 20,000,000
Warrant exercise price		$ 5.95						$ 5.95
Maximum amount of share issuance allowed per quarter								$ 6,000,000
Sale price		$ 5.95						$ 5.95
Cash and cash equivalents		$ 155,205,000						$ 155,205,000			$ 96,791,000
Antidilutive securities excluded from computation of earnings per share								13,141,298	8,043,920
Convertible Senior Notes Due 2023 [Member]
Summary Of Significant Accounting Policies [Line Items]
Debt instrument interest rate		5.00%						5.00%
Senior Facility [Member]
Summary Of Significant Accounting Policies [Line Items]
Maximum aggregate principal amount										$ 59,600,000
Aggregate principal amount borrowed										49,700,000
Additional draw provided		$ 9,900,000						$ 9,900,000		$ 9,900,000

Summary of Significant Accounting Policies - Summary of Impact to Statements of Net Loss and Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Net (loss) income	$ (2,316)	$ (81,687)	$ (184,123)	$ (36,351)	$ (36,301)	$ (29,369)	$ (268,124)	$ (102,021)
Other comprehensive (loss) income	$ 2,458	$ 7,219	$ (16,707)	(4,852)	$ 2,974	$ (456)	$ (7,030)	(2,334)
Unadjusted [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Net (loss) income				(35,678)				(101,032)
Other comprehensive (loss) income				(5,164)				(2,069)
Impact of Adoption [Member] \| ASU 2016-01 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Net (loss) income				(312)				265
Other comprehensive (loss) income				312				(265)
Impact of Adoption [Member] \| ASC 842 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Net (loss) income				(32)				(157)
Impact of Adoption [Member] \| ASU 2018-07 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Net (loss) income				$ (329)				$ (1,097)

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

Assets Held for Sale - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Indefinite-lived intangible asset, Impairment	$ 27,004	$ 106,687
Cultivation License [Member]
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Indefinite-lived intangible asset, Impairment	10,239
High Park Gardens Facility [Member] \| Cannabis Reportable Segment [Member]
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Impairment charges of assets classified as held for sale	25,051
Impairment charge of land and building	13,616
Impairment charge on foreign currency translation adjustments	1,196
High Park Gardens Facility [Member] \| Cannabis Reportable Segment [Member] \| Cultivation License [Member]
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Indefinite-lived intangible asset, Impairment	$ 10,239

Assets Held for Sale - Summary of Assets and Liabilities Comprising Disposal Group Classified as Held for Sale (Detail) - High Park Gardens Facility [Member] - Cannabis Reportable Segment [Member] $ in Thousands	Sep. 30, 2020 USD ($)
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Assets classified as held for sale	$ 6,797
Land and Buildings [Member]
Assets Of Disposal Group Including Discontinued Operation [Line Items]
Assets classified as held for sale	$ 6,797

Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.

Assets Held for Sale - Summary of Pretax (Loss) Income Continuing Operations (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Assets Of Disposal Group Including Discontinued Operation [Abstract]
Pre-tax (loss) income	$ (642)	$ 119	$ (28,335)	$ (396)

ABG Profit Participation Arrangement - Additional Information (Detail) - USD ($)							1 Months Ended	9 Months Ended
	Jan. 01, 2021	Jul. 01, 2020	Jan. 24, 2020	Jan. 01, 2020	Oct. 01, 2019	Apr. 01, 2019	Jan. 31, 2020	Sep. 30, 2019
Class Of Stock [Line Items]
Obligation to pay the additional consideration								$ (17,019,000)
A And R Profit Participation Agreement [Member]
Class Of Stock [Line Items]
Finance receivables write-offs through impairment of assets							$ 7,011,000
Finance receivable write-off through accumulated deficit							$ 28,900,000
ABG Intermediate Holdings Two LLC [Member] \| A And R Profit Participation Agreement [Member]
Class Of Stock [Line Items]
Minimum participation rights with respect to each contract year			$ 10,000,000
ABG Prince Agreement [Member] \| Scenario Forecast [Member]
Class Of Stock [Line Items]
Quarterly royalty payment in 2021, until maturity in 2025	$ 375,000
Class 2 Common Stock [Member] \| ABG Intermediate Holdings Two LLC [Member] \| A And R Profit Participation Agreement [Member]
Class Of Stock [Line Items]
Obligation to pay the additional consideration			$ (83,333,000)
Minimum [Member] \| ABG Intermediate Holdings Two LLC [Member] \| A And R Profit Participation Agreement [Member]
Class Of Stock [Line Items]
Percentage of participation rights			49.00%
Minimum [Member] \| ABG Prince Agreement [Member]
Class Of Stock [Line Items]
Guaranteed minimum royalty payment		$ 500,000		$ 500,000	$ 500,000	$ 500,000

Inventory - Schedule of Inventory (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 15,338	$ 15,926
Work-in-process	59,863	53,973
Finished goods	14,716	17,962
Total Inventory	$ 89,917	$ 87,861

Inventory - Schedule of Inventory Valuation Adjustments Included in Cost of Sales (Detail) - Inventory Valuation and Obsolescence [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Inventory [Line Items]
Inventory valuation adjustments	$ 13,443	$ 201	$ 36,116	$ 726
Raw Materials [Member]
Inventory [Line Items]
Inventory valuation adjustments	173		384
Work In Process [Member]
Inventory [Line Items]
Inventory valuation adjustments	11,164	$ 201	30,656	$ 726
Finished Goods [Member]
Inventory [Line Items]
Inventory valuation adjustments	$ 2,106		$ 5,076

Inventory - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Cannabis [Member]
Inventory [Line Items]
Inventory write-downs	$ 13,318	$ 124	$ 31,626	$ 610
Hemp [Member]
Inventory [Line Items]
Inventory write-downs	125	77	4,490	116
Inventory Valuation Adjustments [Member]
Inventory [Line Items]
Cost of sales	13,443	$ 201	36,116	$ 726
Inventory Valuation Adjustments [Member] \| Termination of Supply Agreement [Member]
Inventory [Line Items]
Cost of sales	5,157		10,090
Inventory Valuation Adjustments [Member] \| Secure Supply [Member]
Inventory [Line Items]
Cost of sales	4,934		4,934
Inventory Valuation Adjustments [Member] \| Additional Termination Penalties [Member]
Inventory [Line Items]
Cost of sales	$ 5,157		5,157
Inventory Valuation Adjustments [Member] \| High Park Gardens Facility [Member]
Inventory [Line Items]
Cost of sales			$ 1,800

Prepayments and Other Current Assets - Schedule of Prepayments and Other Current Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Prepaid Expense And Other Assets Current [Abstract]
Deposits	$ 15,325	$ 25,490
Prepayments	6,854	5,847
Taxes receivable	5,975	6,165
ABG finance receivable - current		671
Total	$ 28,154	$ 38,173

Prepayments and Other Current Assets - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Cannabis [Member]
Prepayments And Other Assets Current [Line Items]
Write off Deposits	$ 4,934

Investments - Summary of Long-term Investments (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Investments Debt And Equity Securities [Abstract]
Equity investments at fair value	$ 2,207	$ 4,183
Equity investments under measurement alternative	14,738	14,954
Debt securities classified under available-for-sale method	5,765	5,047
Total other investments	$ 22,710	$ 24,184

Investments - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
Investments - Additional Information (Detail) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Schedule Of Available For Sale Securities [Line Items]
Unrealized gains (losses) on equity Investments	$ (506,000)	$ (274,000)	$ (1,272,000)	$ 264,000
Impairments or adjustments equity investments under measurement alternative	0	0	0	0
Credit loss expenses	(21,000)	(275,000)	288,000	520,000
Investment in joint venture under the equity method	8,911,000		8,911,000		$ 11,448,000
Fluent [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	5,147,000		5,147,000		7,836,000
Fluent [Member] \| Joint Venture [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	2,323,000	10,090,000	2,323,000	10,090,000
Total fees charged			3,109,000	0
Fluent [Member] \| Joint Venture [Member] \| Accounts Receivable [Member]
Schedule Of Available For Sale Securities [Line Items]
Total fees charged					388,000
Fluent [Member] \| Joint Venture [Member] \| Accounts Payable [Member]
Schedule Of Available For Sale Securities [Line Items]
Total fees charged			441,000
Cannfections [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	3,764,000		3,764,000		3,612,000
Cannfections [Member] \| Joint Venture [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	0	3,600,000	0	3,600,000
Investment in Equities [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, allowance for credit loss	0		0		0
Credit loss expenses	0	$ 0	0	$ 0
Long-term Investments [Member] \| Investment in Equities [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, Gross unrealized loss	$ 148,000		$ 148,000		$ 302,000
Convertible Debt Instrument [Member]
Schedule Of Available For Sale Securities [Line Items]
Convertible debt instruments contractual maturity			2022

Investments - Summary of Ownership Interests in Equity Method Investments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Carrying value	$ 8,911		$ 8,911		$ 11,448
Gain (loss) from equity method investments	$ (1,420)	$ (1,837)	$ (4,495)	$ (1,837)
Fluent [Member]
Schedule Of Equity Method Investments [Line Items]
Approximate ownership %	50.00%		50.00%		50.00%
Carrying value	$ 5,147		$ 5,147		$ 7,836
Gain (loss) from equity method investments			$ (4,725)	$ (1,837)
Cannfections [Member]
Schedule Of Equity Method Investments [Line Items]
Approximate ownership %	50.00%		50.00%		50.00%
Carrying value	$ 3,764		$ 3,764		$ 3,612
Gain (loss) from equity method investments			$ 230

Investments - Summary of Financial Information for Equity Method Investments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Current assets	$ 304,878		$ 304,878		$ 259,027
Current liabilities	133,529		133,529		92,427
Gross profit	3,739	$ 15,853	9,190	$ 33,511
Equity Method Investments [Member]
Schedule Of Equity Method Investments [Line Items]
Revenue			4,854
Gross profit			2,032
Net loss			(8,991)	$ (3,160)
Equity Method Investments [Member] \| Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Schedule Of Equity Method Investments [Line Items]
Current assets	12,346		12,346		13,942
Noncurrent assets	5,205		5,205		4,987
Current liabilities	$ 4,965		$ 4,965		$ 1,561

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Allowance for Credit Losses - Schedule of Allowance for Credit Losses (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Allowance For Credit Loss [Abstract]
Allowance for credit losses, January 1, 2020			$ 615
Provision for expected credit losses	$ (21)	$ (275)	288	$ 520
Write-offs charged against allowance			(74)
Foreign currency translation adjustment			(3)
Allowance for credit losses, September 30, 2020	826		826
Accounts receivable balance before allowance for credit losses and provision for sales returns, September 30, 2020	$ 26,843		$ 26,843

Allowance for Credit Losses - Additional Information (Detail)	Sep. 30, 2020 InvestmentHolding
Allowance For Credit Loss [Abstract]
Number of available for sale debt securities	2
Number of available for sale securities in unrealized loss position	1

Allowance for Credit Losses - Schedule of Fair Value and Unrealized Loss of Investment (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Investments Debt And Equity Securities [Abstract]
Fair value	$ 1,124	$ 945
Unrealized loss	$ 148	$ 302

Property and Equipment, Net - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 211,754	$ 201,334
Less: accumulated depreciation	(24,124)	(17,117)
Total	187,630	184,217
Land [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	6,488	6,417
Buildings and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	108,021	109,172
Laboratory and Manufacturing Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	34,500	31,173
Office and Computer Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	1,779	2,659
Right-of-Use Assets under Finance Lease [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	14,415	14,753
Construction-in-Process, Not Yet Available for Use [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 46,551	$ 37,160

Property and Equipment, Net - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
High Park Gardens Facility [Member]
Property Plant And Equipment [Line Items]
Non-cash impairment charges	$ 13,616

Goodwill - Schedule of Change in Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Goodwill [Line Items]
Balance as of December 31, 2019	$ 163,251
Foreign currency translation adjustment	(3,656)
Balance as of September 30, 2020	159,595
Hemp [Member]
Goodwill [Line Items]
Balance as of December 31, 2019	133,314
Foreign currency translation adjustment	(2,971)
Balance as of September 30, 2020	130,343
Cannabis [Member]
Goodwill [Line Items]
Balance as of December 31, 2019	29,937
Foreign currency translation adjustment	(685)
Balance as of September 30, 2020	$ 29,252

Goodwill - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
Goodwill - Additional Information (Detail) - USD ($)	Mar. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 159,595,000	$ 159,595,000	$ 163,251,000
Goodwill, impaired, facts and circumstances leading to impairment		A relatively small change in the underlying assumptions, including a 1% change in the weighted average cost of capital, continued lack of clarity from the Food and Drug Administration regarding approval of CBD, or the financial performance of the reporting unit in future years, may cause a change in the results of the impairment assessment in future periods and, as such, could result in an impairment of goodwill.
Hemp Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	$ 130,343,000
Reporting unit, percentage of fair value in excess of carrying amount	26.00%
Reporting unit, amount of fair value in excess of carrying amount	$ 76,998,000
Goodwill impairment loss	$ 0
Hemp Reporting Unit [Member] \| Minimum [Member]
Goodwill [Line Items]
Weighted average cost of capital discount rate	10.00%
Hemp Reporting Unit [Member] \| Minimum [Member] \| Revenue and Expense Growth Assumptions [Member]
Goodwill [Line Items]
Reporting unit, percentage of fair value in excess of carrying amount	9.00%
Hemp Reporting Unit [Member] \| Maximum [Member]
Goodwill [Line Items]
Weighted average cost of capital discount rate	12.00%
Hemp Reporting Unit [Member] \| Maximum [Member] \| Revenue and Expense Growth Assumptions [Member]
Goodwill [Line Items]
Reporting unit, percentage of fair value in excess of carrying amount	38.00%

Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	$ 154,596	$ 158,035
Definite-lived intangible asset, Accumulated Amortization	19,680	12,077
Definite-lived intangible asset, Impairment	8,188
Definite-lived intangible asset, Net	126,728	145,958
Indefinite-lived intangible asset, Cost	81,129	189,557
Indefinite-lived intangible asset, Impairment	27,004	106,687
Indefinite-lived intangible asset, Net	54,125	82,870
Total intangible asset, Cost	235,725	347,592
Total intangible asset, Impairment	35,192	106,687
Total intangible asset, Net	180,853	228,828
Patents [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	669	716
Definite-lived intangible asset, Accumulated Amortization	131	99
Definite-lived intangible asset, Impairment	538
Definite-lived intangible asset, Net		617
Customer Relationships [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	132,837	135,953
Definite-lived intangible asset, Accumulated Amortization	13,241	7,132
Definite-lived intangible asset, Net	119,596	128,821
Developed Technology [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	6,912	7,074
Definite-lived intangible asset, Accumulated Amortization	1,094	590
Definite-lived intangible asset, Net	5,818	6,484
Websites [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	5,126	5,157
Definite-lived intangible asset, Accumulated Amortization	3,921	3,331
Definite-lived intangible asset, Net	1,205	1,826
Trademarks and Licenses [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	9,052	9,135
Definite-lived intangible asset, Accumulated Amortization	1,293	925
Definite-lived intangible asset, Impairment	7,650
Definite-lived intangible asset, Net	109	8,210
Cultivation License [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, Cost	10,239	10,689
Indefinite-lived intangible asset, Impairment	10,239
Indefinite-lived intangible asset, Net		10,689
Alef License [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, Cost		4,086
Indefinite-lived intangible asset, Impairment		4,086
Trademarks [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, Cost	54,125	55,416
Indefinite-lived intangible asset, Net	54,125	55,416
Rights under ABG Profit Participation Arrangement [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, Cost	16,765	119,366
Indefinite-lived intangible asset, Impairment	$ 16,765	102,601
Indefinite-lived intangible asset, Net		$ 16,765

Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Non-cash impairment charge of intangible assets				$ 27,004		$ 106,687
Non-cash impairment charge of intangible assets				8,188
Amortization expenses for intangible assets		$ 2,765	$ 2,529	7,603	$ 6,131
Separation from Smith & Sinclair [Member]
Finite Lived Intangible Assets [Line Items]
Additional non-cash impairment charges	$ 3,320
High Park Gardens Facility [Member]
Finite Lived Intangible Assets [Line Items]
Non-cash impairment charge of intangible assets				10,239
ABG Prince Agreement [Member]
Finite Lived Intangible Assets [Line Items]
Non-cash impairment charge of intangible assets				6,063
ABG Profit Participation Agreement [Member]
Finite Lived Intangible Assets [Line Items]
Non-cash impairment charge of intangible assets				$ 16,765
CBD Trademarks and Patents [Member] \| Separation from Smith & Sinclair [Member]
Finite Lived Intangible Assets [Line Items]
Additional non-cash impairment charges	$ 2,126

Intangible Assets - Schedule of Future Amortization Expenses for Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2020 (remaining three months)	$ 2,522
2021	9,801
2022	9,306
2023	9,078
2024	9,078
Thereafter	86,943
Definite-lived intangible asset, Net	$ 126,728	$ 145,958

Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Accrued interest on convertible notes	$ 11,875	$ 5,938
Accrued payroll and employment related withholding taxes	10,709	24,765
Other accrued expenses and current liabilities	8,031	17,032
Accrued interest on Senior Facility	422
Accrued legal and professional fees	364	1,174
Contingent consideration for acquisitions		420
Total accrued expenses and other current liabilities	32,526	50,829
ABG [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
ABG finance liability - current	$ 1,125	$ 1,500

Accrued Expenses and Other Current Liabilities - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Severance Costs	$ 239	$ 0	$ 3,576	$ 0
Cannabis Reportable Segment [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Severance Costs	239		2,432
Hemp Reportable Segment [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Severance Costs	0		1,144
General and Administrative Expense [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Severance Costs	133		3,128
Cost of Sales [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Severance Costs	$ 106		$ 448

Accrued Expenses and Other Current Liabilities - Schedule of Reconciliation of Severance Costs Within Accrued Payroll Related to Scheduled Benefit Payments (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Employee Related Liabilities Current [Abstract]
Additional charges	$ 3,575
Less payments made to employees	(3,393)
Severance costs,Closing Balance	$ 182

Convertible Notes - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Convertible Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 475,000	$ 475,000

Convertible Notes - Schedule of Components of Net Carrying Amount of Convertible Notes (Detail) - Convertible Senior Notes Due 2023 [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
5.00% Convertible Notes	$ 475,000	$ 475,000
Unamortized discount	(28,133)	(34,219)
Unamortized transaction costs	(8,713)	(10,571)
Net carrying amount	$ 438,154	$ 430,210

Convertible Notes - Schedule of Interest Expense Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Amortization of discount			$ 7,944	$ 7,616
Convertible Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Contractual coupon interest	$ 5,938	$ 5,938	17,813	17,813
Amortization of discount	2,059	1,969	6,087	5,790
Amortization of transaction costs	641	614	1,857	1,826
Total	$ 8,638	$ 8,521	$ 25,757	$ 25,429

Senior Facility - Additional Information (Detail)				9 Months Ended
Senior Facility - Additional Information (Detail)	Jun. 05, 2020 USD ($)	Jun. 05, 2020 CAD ($)	Feb. 28, 2020 USD ($)	Sep. 30, 2020	Jun. 29, 2020 USD ($)	Jun. 29, 2020 CAD ($)	Jun. 05, 2020 CAD ($)	Feb. 28, 2020 CAD ($)
Line of Credit Facility [Line Items]
Aggregate repayment amount	$ 47,355,000						$ 64,283,000
Canadian prime rate				8.05%
Senior Secured Term Loan Facility [Member]
Line of Credit Facility [Line Items]
Withdrawal of outstanding request for additional draw	$ 9,900,000						$ 13,300,000
Canadian prime rate				8.05%
Senior Secured Term Loan Facility [Member] \| High Park Holdings Ltd. [Member]
Line of Credit Facility [Line Items]
Maximum aggregate principal amount			$ 59,600,000					$ 79,800,000
Aggregate principal amount borrowed			49,700,000					66,500,000
Amount withdrawable on election			$ 9,900,000					13,300,000
Canadian prime rate			8.05%
Frequency of payment and payment terms			The Company has the option to voluntarily prepay, without penalty, the outstanding amounts, in full or in part, at any time starting 6 months from the closing date subsequent to providing 75 days’ notice.
Transaction fees incurred			$ 3,306,000					4,425,000
Debt instrument, face amount					$ 19,153,000	$ 26,000,000
Minimum unrestricted cash threshold for capital expenditures and investments			$ 29,466,000					$ 40,000,000
Senior Secured Term Loan Facility Amendment [Member]
Line of Credit Facility [Line Items]
Line of credit facility, expiration date	Feb. 28, 2022	Feb. 28, 2022
Additional proceeds available	$ 9,900,000	$ 13,300,000
Senior Secured Term Loan Facility Amendment [Member] \| High Park Gardens Facility [Member]
Line of Credit Facility [Line Items]
Sales proceeds received by the lender	40.00%	40.00%
Sales proceeds retained by the borrower	60.00%	60.00%

Senior Facility - Schedule of Components of Net Carrying Amount of Senior Facility (Detail) - Senior Secured Term Loan Facility [Member] $ in Thousands	Sep. 30, 2020 USD ($)
Debt Instrument [Line Items]
Debt instrument, face amount	$ 48,299
Unamortized transaction costs	(2,355)
Net carrying amount	45,944
Total noncurrent portion of Senior Facility	$ 45,944

Senior Facility - Schedule of Interest Expenses Recognized Related to Senior Facility (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Amortization of discount on convertible notes		$ 7,944	$ 7,616
Senior Secured Term Loan Facility [Member]
Debt Instrument [Line Items]
Contractual interest at Canadian prime plus 8.05%	$ 1,260	2,970
Amortization of discount on convertible notes	407	943
Total	$ 1,667	$ 3,913

Senior Facility - Schedule of Interest Expenses Recognized Related to Senior Facility (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2020
Debt Instrument [Line Items]
Canadian prime rate	8.05%
Senior Secured Term Loan Facility [Member]
Debt Instrument [Line Items]
Canadian prime rate	8.05%

Registered Offering and Warrants - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended				9 Months Ended
	Mar. 17, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020
Class Of Stock [Line Items]
Sale price		$ 5.95				$ 5.95
Warrants to purchase		19,000,000				19,000,000
Warrant exercise price		$ 5.95				$ 5.95
Shares issued for common stock at-the-market, net of issuance costs	$ 90,439	$ 45,230	$ 3,842	$ 27,027	$ 37,445
Issuance costs incurred on registered offering	$ 5,150
Daily cash penalty	1.00%
Level 3 [Member]
Class Of Stock [Line Items]
Estimated fair value of warrant liability per warrant		$ 3.76				3.76
Other Expense (Income) [Member]
Class Of Stock [Line Items]
Issuance costs incurred on registered offering	$ 3,953
Pre funded Warrants [Member]
Class Of Stock [Line Items]
Warrant exercise price		$ 0.0001				$ 0.0001
Warrant Liability [Member]
Class Of Stock [Line Items]
Shares issued for common stock at-the-market, net of issuance costs	$ 69,414
Class 2 Common Stock [Member]
Class Of Stock [Line Items]
Shares issued for common stock at-the-market, net of issuance costs, shares	7,250,000	6,781,090				9,493,494
Sale price	$ 4.76
Warrants to purchase	19,000,000
Warrant exercise price	$ 5.95
Shares issued for common stock at-the-market, net of issuance costs	$ 21,025
Issuance costs incurred on registered offering	$ 1,197					$ 1,540
Class 2 Common Stock [Member] \| Minimum [Member]
Class Of Stock [Line Items]
Warrants expire period	6 months
Class 2 Common Stock [Member] \| Maximum [Member]
Class Of Stock [Line Items]
Warrants expire period	5 years
Class 2 Common Stock [Member] \| Pre funded Warrants [Member]
Class Of Stock [Line Items]
Sale price	$ 4.7599
Warrants to purchase	11,750,000			11,750,000
Warrant exercise price	$ 0.0001			$ 0.0001

Registered Offering and Warrants - Schedule of Pre-funded Warrants and Warrants Outstanding (Detail)	9 Months Ended
	Sep. 30, 2020 $ / shares shares
Class Of Warrant Or Right [Line Items]
Warrant exercise price \| $ / shares	$ 5.95
Warrant issued	30,750,000
Warrant exercised	(11,750,000)
Ending Balance	19,000,000
Pre funded Warrants [Member]
Class Of Warrant Or Right [Line Items]
Warrant description	Pre-Funded Warrants
Warrant classification	Liability
Warrant exercise price \| $ / shares	$ 0.0001
Warrant expiration date	Mar. 17, 2025
Warrant issued	11,750,000
Warrant exercised	(11,750,000)
Warrants [Member]
Class Of Warrant Or Right [Line Items]
Warrant description	Warrants
Warrant classification	Liability
Warrant exercise price \| $ / shares	$ 5.95
Warrant expiration date	Mar. 17, 2025
Warrant issued	19,000,000
Ending Balance	19,000,000

Registered Offering and Warrants - Schedule of Estimated Fair Value of Warrant Liability (Detail) - Warrant [Member] - Level 3 [Member]	Sep. 30, 2020 USD ($) yr
Risk-Free Interest Rate [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	0.0035
Expected Volatility [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	1
Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input \| yr	5
Expected Dividend Yield [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	0
Strike Price [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	5.95
Fair Value of Common Stock [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	4.85

Stockholders' Equity - Summary of Capital Stock (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2020	Sep. 29, 2020
Class 1 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, par value	$ 0.0001
Common stock, shares authorized	233,333,333	250,000,000
Common stock voting rights	10 votes for each share
Class 2 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, par value	$ 0.0001
Common stock, shares authorized	500,000,000
Common stock voting rights	1 vote for each share
Preferred Stock [Member]
Class Of Stock [Line Items]
Convertible preferred stock	$ 0.0001
Convertible preferred stock shares authorized	10,000,000
Convertible preferred stock voting rights	N/A

Stockholders' Equity - Summary of Capital Stock (Parenthetical) (Detail)	Sep. 30, 2020 Vote
Class 1 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, votes for each share	10
Class 2 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, votes for each share	1

Stockholders' Equity - Additional Information (Detail) - USD ($)			3 Months Ended	9 Months Ended
	Sep. 30, 2020	Mar. 17, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 29, 2020	Mar. 31, 2020
Class Of Stock [Line Items]
Warrant exercise price	$ 5.95		$ 5.95	$ 5.95
Warrants to purchase	19,000,000		19,000,000	19,000,000
Proceeds from issuance of common stock, gross		$ 90,439,000	$ 46,153,000
Transaction costs recorded net against allocated gross proceeds in additional paid-in-capital		$ 5,150,000
Maximum allowed aggregate gross proceeds from share issuance under ATM program				$ 20,000,000
Maximum amount of share issuance allowed per quarter				$ 6,000,000
Pre funded Warrants [Member]
Class Of Stock [Line Items]
Warrant exercise price	$ 0.0001		$ 0.0001	$ 0.0001
Class 2 Common Stock [Member]
Class Of Stock [Line Items]
Common stock issued, Shares		7,250,000	6,781,090	9,493,494
Warrant exercise price		$ 5.95
Warrants to purchase		19,000,000
Proceeds from issuance of common stock, gross			$ 46,153,000	$ 76,999,000
Transaction costs recorded net against allocated gross proceeds in additional paid-in-capital		$ 1,197,000		1,540,000
Maximum allowed aggregate gross proceeds from share issuance under ATM program				20,000,000
Maximum amount of share issuance allowed per quarter				$ 6,000,000
Common stock, shares authorized	500,000,000		500,000,000	500,000,000
Common stock, par value	$ 0.0001		$ 0.0001	$ 0.0001
Class 2 Common Stock [Member] \| Pre funded Warrants [Member]
Class Of Stock [Line Items]
Warrant exercise price		$ 0.0001				$ 0.0001
Warrants to purchase		11,750,000				11,750,000
Class 1 Common Stock [Member]
Class Of Stock [Line Items]
Conversion of stock, shares converted	13,159,762
Common stock ceased to represent percentage of outstanding common stock	10.00%
Common stock, shares authorized	233,333,333		233,333,333	233,333,333	250,000,000
Common stock, shares retired	16,666,667		16,666,667	16,666,667
Common stock, par value	$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares outstanding	0		0	0

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation expenses	$ 375		$ 375
Unrecognized stock-based compensation expense to be recognized in period, years			9 months 18 days
Original Stock Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expense	114	$ 143	$ 410	$ 411
Stock options granted			0	0
Fair values of stock option vested			$ 118		$ 2,789
2018 Equity Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expense	7,966	$ 8,501	22,994	$ 21,892
Unrecognized compensation expenses	$ 40,805		$ 40,805
Unrecognized stock-based compensation expense to be recognized in period, years			1 year 10 days
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted			0	10,000
Fair values of stock option vested			$ 31,299		16,708
Weighted average fair values of stock options granted, per share			$ 0	$ 12.01
2018 Equity Incentive Plan [Member] \| Performance-based Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted			0	0
Fair values of stock option vested			$ 0		$ 1,246
2018 Equity Incentive Plan [Member] \| Time-based RSU [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs granted			2,024,334	944,616
Number of RSUs vested			396,051	54,635
2018 Equity Incentive Plan [Member] \| Performance-based RSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs granted			448,230	0
Number of RSUs vested			159,375	731,250
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common shares reserved for issuance, annual automatic increase percentage	4.00%		4.00%
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common stock reserved for issuance, term			10 years
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member] \| Stock Options and Restricted Stock Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares are reserved for issuance	17,037,421		17,037,421		12,926,172

Stock-Based Compensation - Schedule of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Original Stock Option Plan [Member]
Stock options
Shares, Beginning Balance	3,014,004
Shares, Granted	0	0
Shares, Exercised	(528,261)
Shares, Forfeited	(62,153)
Shares, Cancelled	(125,999)
Shares, Ending Balance	2,297,591		3,014,004
Shares, Vested and expected to vest	2,299,283
Shares, Vested and exercisable	2,198,632
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 3.04
Weighted-average exercise price, Exercised	1.15
Weighted-average exercise price, Forfeited	4.44
Weighted-average exercise price, Cancelled	3.30
Weighted-average exercise price, Ending Balance	3.38		$ 3.04
Weighted-average exercise price, Vested and expected to vest	3.37
Weighted-average exercise price, Vested and exercisable	$ 3.22
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	3 years 9 months 18 days		5 years 9 months 18 days
Weighted-average remaining contractual term, Vested and expected to vest	3 years 9 months 18 days
Weighted-average remaining contractual term, Vested and exercisable	3 years 8 months 12 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 32,717		$ 44,108
Aggregate intrinsic value, Vested and expected to vest	32,742
Aggregate intrinsic value, Vested and exercisable	$ 31,750
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Stock options
Shares, Beginning Balance	5,307,130
Shares, Granted	0	10,000
Shares, Exercised	(286,948)
Shares, Forfeited	(245,222)
Shares, Cancelled	(193,127)
Shares, Ending Balance	4,581,833		5,307,130
Shares, Vested and expected to vest	4,511,481
Shares, Vested and exercisable	3,276,183
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 14.04
Weighted-average exercise price, Exercised	7.76
Weighted-average exercise price, Forfeited	13.93
Weighted-average exercise price, Cancelled	13.11
Weighted-average exercise price, Ending Balance	14.48		$ 14.04
Weighted-average exercise price, Vested and expected to vest	14.32
Weighted-average exercise price, Vested and exercisable	$ 12.47
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	7 years 7 months 6 days		8 years 4 months 24 days
Weighted-average remaining contractual term, Vested and expected to vest	7 years 6 months
Weighted-average remaining contractual term, Vested and exercisable	7 years 7 months 6 days
Aggregate intrinsic value
Aggregate intrinsic value			$ 44,297
2018 Equity Incentive Plan [Member] \| Performance-based Stock Options [Member]
Stock options
Shares, Beginning Balance	520,000
Shares, Granted	0	0
Shares, Exercised	(320,000)
Shares, Ending Balance	200,000		520,000
Shares, Vested and expected to vest	200,000
Shares, Vested and exercisable	200,000
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 7.76
Weighted-average exercise price, Exercised	7.76
Weighted-average exercise price, Ending Balance	7.76		$ 7.76
Weighted-average exercise price, Vested and expected to vest	7.76
Weighted-average exercise price, Vested and exercisable	$ 7.76
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	7 years 7 months 6 days		8 years 4 months 24 days
Weighted-average remaining contractual term, Vested and expected to vest	7 years 7 months 6 days
Weighted-average remaining contractual term, Vested and exercisable	7 years 7 months 6 days
Aggregate intrinsic value
Aggregate intrinsic value			$ 4,872

Stock-based Compensation - Schedule of RSU Activity (Detail) - 2018 Equity Incentive Plan [Member] - $ / shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Time-based RSU [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share equivalent, Beginning Balance	1,423,392
Share equivalent, Granted	2,024,334	944,616
Share equivalent, Vested	(396,051)	(54,635)
Share equivalent, Forfeited	(785,641)
Share equivalent, Cancelled	(17,711)
Share equivalent, Ending Balance	2,248,323
Weighted-average grant date fair value, Beginning Balance	$ 42.05
Weighted-average grant date fair value, Granted	8.67
Weighted-average grant date fair value, Vested	45.32
Weighted-average grant date fair value, Forfeited	27.88
Weighted-average grant date fair value, Cancelled	31.31
Weighted-average grant date fair value, Ending Balance	$ 16.46
Performance-based RSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share equivalent, Beginning Balance	265,625
Share equivalent, Granted	448,230	0
Share equivalent, Vested	(159,375)	(731,250)
Share equivalent, Ending Balance	554,480
Weighted-average grant date fair value, Beginning Balance	$ 7.76
Weighted-average grant date fair value, Granted	7.05
Weighted-average grant date fair value, Vested	7.76
Weighted-average grant date fair value, Ending Balance	$ 7.19

Accumulated Other Comprehensive Income (Loss) (AOCI) - Schedule of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	$ 231	$ (6,988)	$ 9,719		$ 9,719
Change in foreign currency translation	2,265	7,184	(16,633)	$ (4,863)	(7,184)	$ (2,414)
Change in unrealized (losses)/ gains on available-for-sale debt securities	193	35	(74)
Ending balance	2,689	231	(6,988)		2,689
Foreign Currency Translation Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	572	(6,612)	10,021		10,021
Change in foreign currency translation	2,265	7,184	(16,633)
Ending balance	2,837	572	(6,612)		2,837
Unrealized (Loss) Gain on Available-for-sale Debt Securities [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(341)	(376)	(302)		(302)
Change in unrealized (losses)/ gains on available-for-sale debt securities	193	35	(74)
Ending balance	$ (148)	$ (341)	$ (376)		$ (148)

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

Commitments and Contingencies - Summary of Maturities of Lease Liabilities (Detail) $ in Thousands	Sep. 30, 2020 USD ($)
Operating leases
2020 (remaining three months)	$ 941
2021	3,576
2022	3,019
2023	2,911
2024	2,489
Thereafter	8,049
Total lease payments	20,985
Imputed interest	2,175
Obligations recognized	18,810
Finance leases
2020 (remaining three months)	235
2021	950
2022	5,389
2023	11,128
Total lease payments	17,702
Imputed interest	3,207
Obligations recognized	$ 14,495

Commitments and Contingencies - Schedule of Future Non-cancellable Minimum Purchase Commitments (Detail) $ in Thousands	Sep. 30, 2020 USD ($)
Purchase Commitment Excluding Longterm Commitment [Line Items]
Total	$ 99,993
2020 (remaining three months)	69,732
2021	30,185
2022	38
2023	38
Purchase Commitments [Member]
Purchase Commitment Excluding Longterm Commitment [Line Items]
Total	99,993
2020 (remaining three months)	69,732
2021	30,185
2022	38
2023	$ 38

Commitments and Contingencies - Additional Information (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($)	Dec. 31, 2018 USD ($) kg
Long Term Purchase Commitment [Line Items]
Estimated compensation fee	$ 10,350,000
Rose Lifescience, Inc [Member]
Long Term Purchase Commitment [Line Items]
Maximum quantity of purchase commitment \| kg		2,000
Purchase commitment price based on cost of goods sold percentage		115.00%
Rose Lifescience, Inc [Member] \| Cannabis [Member]
Long Term Purchase Commitment [Line Items]
Purchase commitment percentage		40.00%
Rose Lifescience, Inc [Member] \| Distribution and Marketing [Member]
Long Term Purchase Commitment [Line Items]
Commitment Term		5 years
Rose Lifescience, Inc [Member] \| Distribution and Marketing [Member] \| Minimum [Member]
Long Term Purchase Commitment [Line Items]
Minimum commitment Fee		$ 384,000

Commitments and Contingencies - Schedule of Other Commitments Maturities (Detail) $ in Thousands	Sep. 30, 2020 USD ($)
Other Commitments [Line Items]
Total	$ 614,161
2020 (remaining three months)	12,133
2021	30,321
2022	74,394
2023	494,313
2024	1,500
Thereafter	1,500
ABG Finance Liability [Member]
Other Commitments [Line Items]
Total	7,500
2021	1,500
2022	1,500
2023	1,500
2024	1,500
Thereafter	1,500
Convertible Notes, Principal and Interest [Member]
Other Commitments [Line Items]
Total	546,251
2020 (remaining three months)	5,938
2021	23,750
2022	23,750
2023	492,813
Senior Facility, Principal and Interest [Member]
Other Commitments [Line Items]
Total	55,483
2020 (remaining three months)	1,268
2021	5,071
2022	49,144
Portugal Construction Commitments [Member]
Other Commitments [Line Items]
Total	4,927
2020 (remaining three months)	$ 4,927

Revenue from Contracts with Customers (Detail)	9 Months Ended
Revenue from Contracts with Customers (Detail)	Sep. 30, 2020 USD ($) Segment	Dec. 31, 2019 USD ($)
Revenue From Contract With Customer [Abstract]
Number of reportable segments \| Segment	2
Contract balances in the balance sheets \| $	$ 0	$ 0

General and Administrative Expenses - Schedule of General and Administrative Expenses (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
General And Administrative Expense [Abstract]
Salaries	$ 8,323	$ 8,637	$ 24,365	$ 22,289
Other expenses	2,367	4,261	12,803	10,651
Professional fees	1,407	6,051	9,750	12,716
Loss on disposal of property and equipment	457		885	112
Travel expenses	132	1,448	939	3,330
Credit loss expenses	(21)	(275)	288	520
Total	$ 12,665	$ 20,122	$ 49,030	$ 49,618

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Noncash Or Part Noncash Acquisitions [Line Items]
Cash paid for interest	$ 10,367	$ 17,613
Cash paid for income taxes	$ 272
Manitoba Harvest [Member]
Non-cash investing
Acquisition of Manitoba Harvest, Natura		157,917
Natura [Member]
Non-cash investing
Acquisition of Manitoba Harvest, Natura		38,980
Investment In ABG [Member]
Non-cash investing
Investment in ABG Profit Participation Arrangement, net of receivable		94,805
Investments and S&S [Member]
Non-cash investing
Purchases of investments and S&S acquisition		$ 14,508

Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,672	$ 1,524
Operating cash flows from finance leases	445
Financing cash flows from finance leases	309
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases	$ 423	$ 14,897

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Annual lease payments	$ 20,985		$ 20,985
Accounts payable to related party	$ 141		$ 141		$ 68
Cannfections [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%		50.00%
Fluent [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%		50.00%
Ten Eleven [Member]
Related Party Transaction [Line Items]
Annual lease payments	$ 470		$ 470
Sub-leases expiration period			May 31, 2020
Joint Venture [Member] \| Cannfections [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%
Percentage of voting interest	50.00%		50.00%
Joint Venture [Member] \| Fluent [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%
Percentage of voting interest	50.00%		50.00%
General and Administrative Expense [Member] \| Aircraft Time Share Reimbursement [Member]
Related Party Transaction [Line Items]
Payment for use of aircraft	$ 0	$ 0	$ 261	$ 0
General and Administrative Expense [Member] \| Leafly Holdings, Inc [Member]
Related Party Transaction [Line Items]
Operational expenses	5	130	134	149
General and Administrative Expense [Member] \| Docklight L L C
Related Party Transaction [Line Items]
Management service fees expense	$ 331	44	748	176
General and Administrative Expense [Member] \| Ten Eleven [Member]
Related Party Transaction [Line Items]
Management service fees expense		75	71	200
Other Income, Net [Member] \| Ten Eleven [Member]
Related Party Transaction [Line Items]
Sublease income		$ 115	$ 196	$ 192

Financial Instruments - Additional Information (Detail) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)
Financial Instruments [Abstract]
Change in exchange rate		10.00%
Carrying value of net asset		$ 23,578
Canadian prime rate		8.05%
Convertible notes, fixed interest rate	5.00%	5.00%
Change in Canadian prime rate		1.00%
Loss due to one percentage change in Canadian prime rate	$ 127	$ 295

Fair Value Measurement - Schedule of Assets Measured Fair Value on Recurring Basis (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	$ (71,636)
Total recurring fair value measurements	(63,664,000)	$ 8,810,000
Acquisition-related contingent consideration		(420,000)
Fair Value, Measurements, Recurring [Member] \| Equity Investments Measured at Fair Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	2,207,000	4,183,000
Fair Value, Measurements, Recurring [Member] \| Debt Securities Classified as Available-for-Sale [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	5,765,000	5,047,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total recurring fair value measurements	3,051,000	4,910,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member] \| Equity Investments Measured at Fair Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	2,207,000	4,183,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member] \| Debt Securities Classified as Available-for-Sale [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	844,000	727,000
Level 3 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	(71,636)
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	(71,636)
Total recurring fair value measurements	(66,715,000)	3,900,000
Acquisition-related contingent consideration		(420,000)
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member] \| Debt Securities Classified as Available-for-Sale [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	$ 4,921,000	$ 4,320,000

Fair Value Measurement - Summary of Opening Balances of Assets and Liabilities Categorized Within Level 3 of the Fair Value Hierarchy Measured at Fair Value on a Recurring Basis (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Fair Value Disclosures [Abstract]
Debt securities classified as available-for-sale, Beginning Balance	$ 4,320
Debt securities classified as available-for-sale, Interest expenses, net	601
Debt securities classified as available-for-sale, Ending Balance	4,921
Warrant liability, Additions	(69,414)
Warrant liability, Exercise	49,053
Warrant liability, Change in fair value of warrant liability	(51,275)
Warrant liability, Ending Balance	$ (71,636)

Fair Value Measurement - Summary of Quantitative Information about Level 3 Fair Value Measurements (Detail)	Sep. 30, 2020 USD ($) yr	Dec. 31, 2019 USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair value of, Debt securities classified as available-for-sale \| $	$ 5,765,000	$ 5,047,000
Quantitative information about Level 3 Fair Value Measurements [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair value of, Debt securities classified as available-for-sale \| $	$ 4,921,000
Debt Securities, Available-for-sale, Valuation Technique [Extensible List]	us-gaap:ValuationTechniqueDiscountedCashFlowMember
Warrant liability \| $	$ (71,636)
Warrants and Rights Outstanding, Valuation Technique [Extensible List]	tlry:ValuationTechniqueMonteCarloMember
Quantitative information about Level 3 Fair Value Measurements [Member] \| Discount Rate [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt securities classified as available-for-sale, Range	16.5
Quantitative information about Level 3 Fair Value Measurements [Member] \| Probability of Conversion/ Prepayment [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt securities classified as available-for-sale, Range
Quantitative information about Level 3 Fair Value Measurements [Member] \| Probability of Default [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt securities classified as available-for-sale, Range
Quantitative information about Level 3 Fair Value Measurements [Member] \| Volatility [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input	100
Quantitative information about Level 3 Fair Value Measurements [Member] \| Minimum [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input \| yr	0.2
Quantitative information about Level 3 Fair Value Measurements [Member] \| Maximum [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input \| yr	5
Quantitative information about Level 3 Fair Value Measurements [Member] \| Weighted Average [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input \| yr	2.4

Business Segment Information - Additional Information (Detail)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) Segment	Sep. 30, 2019 USD ($)	Dec. 31, 2019
Segment Reporting Information [Line Items]
Number of operating segment \| Segment			2
Revenue	$ 51,406,000	$ 51,101,000	$ 153,922,000	$ 120,043,000
Excise duties	$ 4,213,000	$ 2,931,000	$ 13,325,000	$ 8,707,000
Customer Concentration Risk [Member] \| Revenue [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	21.00%	20.00%	20.00%	12.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Customer B [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	19.00%	14.00%	18.00%	11.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Customer C [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		10.00%	11.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage			20.00%		20.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer B [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage			11.00%		10.00%
Intersegment Sales or Transfers [Member]
Segment Reporting Information [Line Items]
Revenue			$ 0

Business Segment Information - Summary of Revenue and Gross Profit of each Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenue	$ 51,406	$ 51,101	$ 153,922	$ 120,043
Gross profit / (loss)	3,739	15,853	9,190	33,511
Cannabis [Member]
Segment Reporting Information [Line Items]
Revenue	31,426	35,451	92,373	78,876
Gross profit / (loss)	(4,717)	9,225	(13,863)	16,213
Hemp [Member]
Segment Reporting Information [Line Items]
Revenue	19,980	15,650	61,549	41,167
Gross profit / (loss)	$ 8,456	$ 6,628	$ 23,053	$ 17,298

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Business Segment Information - Summary of Revenue and Gross Profit (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting [Abstract]
Gross profit	$ 3,739	$ 15,853	$ 9,190	$ 33,511
General and administrative expenses	12,665	20,122	49,030	49,618
Sales and marketing expenses	10,000	16,974	40,709	39,161
Research and development expenses	921	2,315	2,831	4,891
Depreciation and amortization expenses	3,425	3,200	10,353	7,457
Stock-based compensation expenses	8,080	8,644	23,404	22,303
Impairment of assets			58,210
Acquisition-related expenses (income), net		(13,454)		(6,566)
Loss from equity method investments	1,420	1,837	4,495	1,837
Foreign exchange (gain) loss, net	(9,319)	2,585	5,424	1,153
Change in fair value of warrant liability	(31,913)		51,275
Interest expenses, net	10,437	8,680	30,147	26,005
Finance income from ABG		(210)		(557)
Other expense (income), net	(38)	(1,116)	4,944	(6,185)
Loss before income taxes	$ (1,939)	$ (33,724)	$ (271,632)	$ (105,606)

Business Segment Information - Summary of Sources of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 51,406	$ 51,101	$ 153,922	$ 120,043
Dried Cannabis [Member]
Segment Reporting Information [Line Items]
Revenues	21,079	29,412	61,339	62,214
Cannabis Extracts [Member]
Segment Reporting Information [Line Items]
Revenues	10,239	5,819	30,246	16,172
Hemp Products [Member]
Segment Reporting Information [Line Items]
Revenues	19,980	15,650	61,549	41,167
Accessories And Other [Member]
Segment Reporting Information [Line Items]
Revenues	$ 108	$ 220	$ 788	$ 490

Business Segment Information - Summary of Channels of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenue	$ 51,406	$ 51,101	$ 153,922	$ 120,043
Cannabis [Member]
Segment Reporting Information [Line Items]
Revenue	31,426	35,451	92,373	78,876
Cannabis [Member] \| Adult-use [Member]
Segment Reporting Information [Line Items]
Revenue	19,926	15,835	58,466	38,758
Cannabis [Member] \| Canada - medical [Member]
Segment Reporting Information [Line Items]
Revenue	3,399	3,898	11,285	9,222
Cannabis [Member] \| International - medical [Member]
Segment Reporting Information [Line Items]
Revenue	8,101	5,708	22,220	9,370
Cannabis [Member] \| Bulk [Member]
Segment Reporting Information [Line Items]
Revenue		10,010	402	21,526
Hemp [Member]
Segment Reporting Information [Line Items]
Revenue	$ 19,980	$ 15,650	$ 61,549	$ 41,167

Business Segment Information - Summary of Revenues Attributed to a Geographic Region Based on the Location of the Customer (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 51,406	$ 51,101	$ 153,922	$ 120,043
CANADA [Member]
Segment Reporting Information [Line Items]
Revenues	29,475	33,585	86,807	81,138
UNITED STATES [Member]
Segment Reporting Information [Line Items]
Revenues	13,340	10,836	43,851	28,407
Other Countries [Member]
Segment Reporting Information [Line Items]
Revenues	$ 8,591	$ 6,680	$ 23,264	$ 10,498